The pathogenesis of Parkinson's disease
Parkinson's disease is a progressive neurodegenerative condition associated with the deposition of aggregated α-synuclein. Insights into the pathogenesis of Parkinson's disease have been derived from genetics and molecular pathology. Biochemical studies, investigation of transplanted neuro...
Uloženo v:
| Vydáno v: | The Lancet (British edition) Ročník 403; číslo 10423; s. 293 - 304 |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
England
Elsevier Ltd
20.01.2024
Elsevier Limited |
| Témata: | |
| ISSN: | 0140-6736, 1474-547X, 1474-547X |
| On-line přístup: | Získat plný text |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | Parkinson's disease is a progressive neurodegenerative condition associated with the deposition of aggregated α-synuclein. Insights into the pathogenesis of Parkinson's disease have been derived from genetics and molecular pathology. Biochemical studies, investigation of transplanted neurons in patients with Parkinson's disease, and cell and animal model studies suggest that abnormal aggregation of α-synuclein and spreading of pathology between the gut, brainstem, and higher brain regions probably underlie the development and progression of Parkinson's disease. At a cellular level, abnormal mitochondrial, lysosomal, and endosomal function can be identified in both monogenic and sporadic Parkinson's disease, suggesting multiple potential treatment approaches. Recent work has also highlighted maladaptive immune and inflammatory responses, possibly triggered in the gut, that accelerate the pathogenesis of Parkinson's disease. Although there are currently no disease-modifying treatments for Parkinson's disease, we now have a solid basis for the development of rational neuroprotective therapies that we hope will halt the progression of this disabling neurological condition. |
|---|---|
| AbstractList | Summary Parkinson's disease is a progressive neurodegenerative condition associated with the deposition of aggregated α-synuclein. Insights into the pathogenesis of Parkinson's disease have been derived from genetics and molecular pathology. Biochemical studies, investigation of transplanted neurons in patients with Parkinson's disease, and cell and animal model studies suggest that abnormal aggregation of α-synuclein and spreading of pathology between the gut, brainstem, and higher brain regions probably underlie the development and progression of Parkinson's disease. At a cellular level, abnormal mitochondrial, lysosomal, and endosomal function can be identified in both monogenic and sporadic Parkinson's disease, suggesting multiple potential treatment approaches. Recent work has also highlighted maladaptive immune and inflammatory responses, possibly triggered in the gut, that accelerate the pathogenesis of Parkinson's disease. Although there are currently no disease-modifying treatments for Parkinson's disease, we now have a solid basis for the development of rational neuroprotective therapies that we hope will halt the progression of this disabling neurological condition. Parkinson's disease is a progressive neurodegenerative condition associated with the deposition of aggregated α-synuclein. Insights into the pathogenesis of Parkinson's disease have been derived from genetics and molecular pathology. Biochemical studies, investigation of transplanted neurons in patients with Parkinson's disease, and cell and animal model studies suggest that abnormal aggregation of α-synuclein and spreading of pathology between the gut, brainstem, and higher brain regions probably underlie the development and progression of Parkinson's disease. At a cellular level, abnormal mitochondrial, lysosomal, and endosomal function can be identified in both monogenic and sporadic Parkinson's disease, suggesting multiple potential treatment approaches. Recent work has also highlighted maladaptive immune and inflammatory responses, possibly triggered in the gut, that accelerate the pathogenesis of Parkinson's disease. Although there are currently no disease-modifying treatments for Parkinson's disease, we now have a solid basis for the development of rational neuroprotective therapies that we hope will halt the progression of this disabling neurological condition. Parkinson's disease is a progressive neurodegenerative condition associated with the deposition of aggregated α-synuclein. Insights into the pathogenesis of Parkinson's disease have been derived from genetics and molecular pathology. Biochemical studies, investigation of transplanted neurons in patients with Parkinson's disease, and cell and animal model studies suggest that abnormal aggregation of α-synuclein and spreading of pathology between the gut, brainstem, and higher brain regions probably underlie the development and progression of Parkinson's disease. At a cellular level, abnormal mitochondrial, lysosomal, and endosomal function can be identified in both monogenic and sporadic Parkinson's disease, suggesting multiple potential treatment approaches. Recent work has also highlighted maladaptive immune and inflammatory responses, possibly triggered in the gut, that accelerate the pathogenesis of Parkinson's disease. Although there are currently no disease-modifying treatments for Parkinson's disease, we now have a solid basis for the development of rational neuroprotective therapies that we hope will halt the progression of this disabling neurological condition.Parkinson's disease is a progressive neurodegenerative condition associated with the deposition of aggregated α-synuclein. Insights into the pathogenesis of Parkinson's disease have been derived from genetics and molecular pathology. Biochemical studies, investigation of transplanted neurons in patients with Parkinson's disease, and cell and animal model studies suggest that abnormal aggregation of α-synuclein and spreading of pathology between the gut, brainstem, and higher brain regions probably underlie the development and progression of Parkinson's disease. At a cellular level, abnormal mitochondrial, lysosomal, and endosomal function can be identified in both monogenic and sporadic Parkinson's disease, suggesting multiple potential treatment approaches. Recent work has also highlighted maladaptive immune and inflammatory responses, possibly triggered in the gut, that accelerate the pathogenesis of Parkinson's disease. Although there are currently no disease-modifying treatments for Parkinson's disease, we now have a solid basis for the development of rational neuroprotective therapies that we hope will halt the progression of this disabling neurological condition. |
| Author | Williams-Gray, Caroline H Morris, Huw R Spillantini, Maria Grazia Sue, Carolyn M |
| Author_xml | – sequence: 1 givenname: Huw R surname: Morris fullname: Morris, Huw R email: h.morris@ucl.ac.uk organization: Department of Clinical and Movement Neurosciences, Queen Square Institute of Neurology, University College London, London, UK – sequence: 2 givenname: Maria Grazia surname: Spillantini fullname: Spillantini, Maria Grazia organization: Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK – sequence: 3 givenname: Carolyn M surname: Sue fullname: Sue, Carolyn M email: c.sue@neura.edu.au organization: Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia – sequence: 4 givenname: Caroline H surname: Williams-Gray fullname: Williams-Gray, Caroline H organization: John Van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38245249$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNkE1LAzEURYMo2lZ_glJw0boYzffMICJS_AJBwQruQibzRqPTpCZTof_eqVUX3dRVXuDc-x6nizadd4DQPsHHBBN58ogJx4lMmRxSdtR-0iyhG6jTDjwRPH3eRJ0_ZAd1Y3zDGHOJxTbaYRnlgvK8gwbjV-hPdfPqX8BBtLHvq_6DDu_WRe8GsV_aCDrCLtqqdB1h7-ftoaery_HoJrm7v74dXdwlhknaJJCXWmrOhC6qAleVKFPDsQCKOcMSGHBqONcihTLjmBgsZUYELcpMkqqQFeuh4bJ3GvzHDGKjJjYaqGvtwM-iojlJhSAiJS16uIK--Vlw7XULKk-znDDWUgc_1KyYQKmmwU50mKtfBS1wugRM8DEGqJSxjW6sd03QtlYEq4Vw9S1cLWwqytS38HboIbGS_l2wLne-zEEr89NCUNFYcAZKG8A0qvR2bcPZSoOprbNG1-8w_0f-Cyvxp94 |
| CitedBy_id | crossref_primary_10_1016_j_jare_2025_05_039 crossref_primary_10_1016_j_ynstr_2025_100762 crossref_primary_10_1007_s43440_025_00756_z crossref_primary_10_1186_s40035_024_00437_6 crossref_primary_10_1007_s10787_024_01557_1 crossref_primary_10_1093_jb_mvaf037 crossref_primary_10_1002_smll_202410030 crossref_primary_10_1038_s41598_025_08740_6 crossref_primary_10_1093_gerona_glaf124 crossref_primary_10_1016_j_intimp_2024_113608 crossref_primary_10_1016_j_brainresbull_2025_111253 crossref_primary_10_1186_s12993_025_00289_8 crossref_primary_10_3390_ijms252111663 crossref_primary_10_1016_j_neulet_2024_137887 crossref_primary_10_3390_biom14121579 crossref_primary_10_1016_j_neuint_2025_106014 crossref_primary_10_1002_acn3_70018 crossref_primary_10_1002_slct_202404978 crossref_primary_10_2147_IJN_S526945 crossref_primary_10_4103_NRR_NRR_D_24_01343 crossref_primary_10_1016_j_neuro_2024_12_003 crossref_primary_10_5498_wjp_v15_i8_108704 crossref_primary_10_1016_j_intimp_2025_115089 crossref_primary_10_1016_j_bbr_2025_115826 crossref_primary_10_3233_JPD_240092 crossref_primary_10_3389_fnagi_2025_1535310 crossref_primary_10_1016_j_bbr_2024_115200 crossref_primary_10_1016_j_colsurfb_2025_114585 crossref_primary_10_1016_j_ncl_2024_12_009 crossref_primary_10_1002_ame2_70039 crossref_primary_10_3389_fnmol_2025_1642590 crossref_primary_10_7717_peerj_19818 crossref_primary_10_3897_pharmacia_72_e164727 crossref_primary_10_1038_s41531_024_00819_7 crossref_primary_10_2147_IJGM_S499406 crossref_primary_10_1016_j_biopha_2025_118526 crossref_primary_10_1016_j_compmedimag_2024_102490 crossref_primary_10_1080_01616412_2024_2381162 crossref_primary_10_1016_j_ncl_2024_12_013 crossref_primary_10_3389_fnagi_2024_1437138 crossref_primary_10_1002_mds_30229 crossref_primary_10_3390_ph18060831 crossref_primary_10_1007_s11010_025_05299_8 crossref_primary_10_1007_s10735_025_10532_1 crossref_primary_10_1038_s41598_025_07735_7 crossref_primary_10_1109_ACCESS_2024_3408680 crossref_primary_10_1016_j_ebiom_2025_105917 crossref_primary_10_1016_j_intimp_2024_113938 crossref_primary_10_1007_s12035_024_04654_y crossref_primary_10_1016_j_ccr_2025_216959 crossref_primary_10_1016_j_ejphar_2024_176690 crossref_primary_10_1016_j_neuropharm_2024_110063 crossref_primary_10_1631_jzus_B2400186 crossref_primary_10_1360_TB_2024_1164 crossref_primary_10_1002_mds_30047 crossref_primary_10_1371_journal_pone_0328682 crossref_primary_10_1126_scisignal_ads5761 crossref_primary_10_1016_j_molmed_2025_01_009 crossref_primary_10_1186_s12951_025_03104_8 crossref_primary_10_3390_cells13100799 crossref_primary_10_1016_j_jneuroim_2025_578716 crossref_primary_10_3389_fnins_2025_1576773 crossref_primary_10_1080_14737175_2025_2450789 crossref_primary_10_3389_fphar_2024_1436597 crossref_primary_10_1007_s00415_025_13288_6 crossref_primary_10_1093_cercor_bhaf097 crossref_primary_10_1016_j_exger_2025_112762 crossref_primary_10_3748_wjg_v31_i15_104875 crossref_primary_10_3390_biom15010033 crossref_primary_10_1016_j_expneurol_2025_115411 crossref_primary_10_3390_jcm13185642 crossref_primary_10_1007_s42114_025_01336_8 crossref_primary_10_1016_j_metrad_2025_100182 crossref_primary_10_3390_antiox13121462 crossref_primary_10_3390_ph18091298 crossref_primary_10_1038_s42003_024_06896_x crossref_primary_10_1016_j_tins_2025_04_004 crossref_primary_10_1016_j_parkreldis_2024_107250 crossref_primary_10_1007_s11030_025_11198_3 crossref_primary_10_1016_j_jep_2025_119705 crossref_primary_10_3389_fcell_2025_1646072 crossref_primary_10_1177_1934578X251328242 crossref_primary_10_1038_s41531_025_01087_9 crossref_primary_10_1186_s12950_024_00426_6 crossref_primary_10_1016_S1474_4422_24_00378_8 crossref_primary_10_2147_JIR_S526777 crossref_primary_10_3233_JPD_240155 crossref_primary_10_3389_fcell_2025_1577382 crossref_primary_10_3390_cells14030163 crossref_primary_10_54133_ajms_v8i2_1728 crossref_primary_10_1016_j_tjnut_2025_01_028 crossref_primary_10_1016_j_biopha_2024_117419 crossref_primary_10_1016_j_fmre_2024_12_023 crossref_primary_10_2147_JPR_S485481 crossref_primary_10_3390_healthcare13151873 crossref_primary_10_1016_j_ejphar_2025_177748 crossref_primary_10_1186_s13020_025_01135_9 crossref_primary_10_1007_s00702_025_02989_x crossref_primary_10_1096_fj_202500556R crossref_primary_10_1007_s13346_025_01799_8 crossref_primary_10_1007_s11011_024_01452_2 crossref_primary_10_3390_ijms26062411 crossref_primary_10_1021_acs_est_5c02319 crossref_primary_10_1016_j_compbiomed_2025_110177 crossref_primary_10_1007_s11033_025_10381_x crossref_primary_10_1002_brb3_70659 crossref_primary_10_1021_acschemneuro_5c00127 crossref_primary_10_1159_000547706 crossref_primary_10_1177_10538135251320263 crossref_primary_10_1016_j_phymed_2024_156296 crossref_primary_10_1038_s41598_025_10994_z crossref_primary_10_1016_j_brainres_2025_149568 crossref_primary_10_1021_acs_analchem_5c02829 crossref_primary_10_1371_journal_pone_0311140 crossref_primary_10_3389_fimmu_2025_1526095 crossref_primary_10_1007_s10787_025_01811_0 crossref_primary_10_3389_fneur_2025_1548322 crossref_primary_10_1016_j_gerinurse_2024_09_021 crossref_primary_10_32604_biocell_2024_049130 crossref_primary_10_4103_AGINGADV_AGINGADV_D_25_00007 crossref_primary_10_1007_s12035_025_04829_1 crossref_primary_10_1038_s41531_025_00928_x crossref_primary_10_1007_s13205_025_04314_5 crossref_primary_10_3390_ijms25073929 crossref_primary_10_1126_science_adp3645 crossref_primary_10_1111_cns_70605 crossref_primary_10_1016_j_expneurol_2025_115287 crossref_primary_10_1021_acschemneuro_5c00035 crossref_primary_10_1016_j_arr_2024_102553 crossref_primary_10_1038_s41531_025_00980_7 crossref_primary_10_1016_j_phrs_2024_107507 crossref_primary_10_1016_j_ijpharm_2024_125054 crossref_primary_10_1016_j_phrs_2025_107947 crossref_primary_10_1055_a_2557_8422 crossref_primary_10_3390_pharmaceutics16121611 crossref_primary_10_1016_j_molmed_2025_03_008 crossref_primary_10_1007_s11481_025_10209_2 crossref_primary_10_1016_j_tins_2024_06_005 crossref_primary_10_1038_s41419_025_07504_4 crossref_primary_10_1093_burnst_tkaf011 crossref_primary_10_1002_adma_202418723 crossref_primary_10_1038_s41586_025_08845_y crossref_primary_10_1007_s11033_025_10966_6 crossref_primary_10_1016_j_arr_2025_102728 crossref_primary_10_4103_NRR_NRR_D_24_00994 crossref_primary_10_3389_fnagi_2025_1540830 crossref_primary_10_3389_fphar_2025_1566479 crossref_primary_10_1016_j_taap_2025_117478 crossref_primary_10_26508_lsa_202402922 crossref_primary_10_1080_14728222_2024_2404571 crossref_primary_10_1016_j_bcp_2025_117301 crossref_primary_10_1016_j_neuropharm_2024_110241 crossref_primary_10_1016_j_heliyon_2024_e32533 crossref_primary_10_1080_01652176_2025_2450041 crossref_primary_10_3390_molecules29184498 crossref_primary_10_1242_dmm_050858 crossref_primary_10_1016_j_snb_2025_137703 crossref_primary_10_1016_j_ejphar_2025_177782 crossref_primary_10_1016_j_bbi_2024_11_023 crossref_primary_10_1002_mdc3_14254 crossref_primary_10_1016_j_jnrt_2025_100204 crossref_primary_10_3923_ijp_2025_1_15 crossref_primary_10_3390_cells13040338 crossref_primary_10_1038_s41593_024_01867_1 crossref_primary_10_1016_j_neuropharm_2024_110217 crossref_primary_10_1016_j_arr_2025_102856 crossref_primary_10_26599_NBE_2025_9290117 crossref_primary_10_1042_BCJ20253062 crossref_primary_10_3389_fneur_2025_1581045 crossref_primary_10_1016_j_lfs_2025_123789 crossref_primary_10_1002_mdc3_14264 crossref_primary_10_3389_fnins_2025_1584555 crossref_primary_10_1038_s41392_024_02013_w crossref_primary_10_1016_j_neuint_2025_106054 crossref_primary_10_1097_CM9_0000000000003802 crossref_primary_10_1016_j_jrras_2025_101876 crossref_primary_10_1016_j_neuint_2025_106053 crossref_primary_10_1038_s41401_025_01576_w crossref_primary_10_1186_s40001_025_02921_9 crossref_primary_10_3389_fimmu_2024_1454102 crossref_primary_10_1134_S0022093025010223 crossref_primary_10_3390_biomedicines13041003 crossref_primary_10_1002_alz_70670 crossref_primary_10_1016_j_ejphar_2025_177644 crossref_primary_10_35366_120411 crossref_primary_10_1080_15622975_2025_2530750 crossref_primary_10_1097_jagr_0000000000000024 crossref_primary_10_1016_j_expneurol_2024_115040 crossref_primary_10_1016_j_jff_2025_106717 crossref_primary_10_3389_fnins_2024_1469903 crossref_primary_10_3390_biology13110893 crossref_primary_10_3897_bsms_7_144070 crossref_primary_10_3390_ijms25189947 crossref_primary_10_1016_j_phymed_2025_156652 crossref_primary_10_1109_ACCESS_2024_3480458 crossref_primary_10_1016_j_bbr_2025_115804 crossref_primary_10_1007_s40120_024_00687_6 crossref_primary_10_1016_j_arr_2024_102583 crossref_primary_10_1042_BST20240087 crossref_primary_10_3390_ijms26020620 crossref_primary_10_1038_s41467_025_58825_z crossref_primary_10_3389_fpsyt_2024_1524555 crossref_primary_10_3389_fnagi_2025_1596392 crossref_primary_10_3389_fphar_2024_1437939 crossref_primary_10_3389_fnagi_2024_1411320 crossref_primary_10_1002_acn3_52282 crossref_primary_10_1002_INMD_20250005 crossref_primary_10_1039_D4BM01394H crossref_primary_10_1134_S0006297924070113 crossref_primary_10_3389_fnagi_2025_1440850 crossref_primary_10_1053_j_semnuclmed_2024_09_004 crossref_primary_10_1038_s41597_024_03909_6 crossref_primary_10_1186_s12889_025_23492_8 crossref_primary_10_1007_s10753_025_02306_4 crossref_primary_10_1002_advs_202503579 crossref_primary_10_1021_acsnano_5c01068 crossref_primary_10_7759_cureus_90055 crossref_primary_10_1021_acschemneuro_5c00087 crossref_primary_10_1186_s12883_024_03857_z crossref_primary_10_1038_s41531_025_01127_4 crossref_primary_10_1186_s40035_025_00482_9 crossref_primary_10_3390_cells13221876 crossref_primary_10_1021_acs_chemrestox_5c00058 crossref_primary_10_1038_s41531_025_00971_8 crossref_primary_10_1016_j_acra_2025_04_001 crossref_primary_10_1016_j_nbd_2025_106984 crossref_primary_10_1039_D4MD00576G crossref_primary_10_3390_ijms252413578 crossref_primary_10_1016_j_phymed_2025_157262 crossref_primary_10_1007_s00204_025_04174_1 crossref_primary_10_1186_s12974_025_03396_5 crossref_primary_10_1021_acs_jafc_5c06844 crossref_primary_10_1080_00207454_2025_2501651 crossref_primary_10_1016_j_intimp_2025_114539 crossref_primary_10_3389_fneur_2024_1407241 crossref_primary_10_1186_s12967_024_05535_7 crossref_primary_10_3390_biom14060673 crossref_primary_10_3389_fphar_2025_1504245 crossref_primary_10_1007_s11033_025_10345_1 crossref_primary_10_1111_cts_13898 crossref_primary_10_3390_antiox14080963 crossref_primary_10_1038_s41531_024_00846_4 crossref_primary_10_1080_17520363_2025_2468151 crossref_primary_10_1007_s00335_025_10128_w crossref_primary_10_1016_j_prdoa_2025_100360 crossref_primary_10_1097_MD_0000000000039405 crossref_primary_10_1080_21688370_2025_2504744 crossref_primary_10_3390_cells14151161 crossref_primary_10_1016_j_prdoa_2025_100359 crossref_primary_10_3390_biomedicines13030747 crossref_primary_10_1002_INMD_20240013 crossref_primary_10_1186_s13041_025_01218_6 crossref_primary_10_3390_ijms26062695 crossref_primary_10_1016_j_jbc_2025_110449 crossref_primary_10_1016_j_brainresbull_2024_111110 crossref_primary_10_1016_j_intimp_2025_115443 crossref_primary_10_3389_fimmu_2025_1656729 crossref_primary_10_1007_s00415_025_13325_4 crossref_primary_10_1016_j_ejmech_2025_117452 crossref_primary_10_1016_j_neuroscience_2025_01_038 crossref_primary_10_1016_j_ijbiomac_2025_143986 crossref_primary_10_1007_s12035_025_05172_1 crossref_primary_10_1002_imt2_70076 crossref_primary_10_1016_j_smhs_2025_05_004 crossref_primary_10_3389_fgene_2025_1526018 crossref_primary_10_1021_acsnano_5c06227 crossref_primary_10_3390_ijms25179197 crossref_primary_10_1016_j_intimp_2025_114201 crossref_primary_10_1016_j_prdoa_2025_100344 crossref_primary_10_1111_cpr_13804 crossref_primary_10_1016_j_arr_2024_102517 crossref_primary_10_1016_j_freeradbiomed_2024_09_030 crossref_primary_10_3390_ijms251910484 crossref_primary_10_3389_fmicb_2025_1583562 crossref_primary_10_1002_ana_27242 crossref_primary_10_1038_s41423_024_01181_7 crossref_primary_10_1002_advs_202501694 crossref_primary_10_1016_j_isci_2025_112385 crossref_primary_10_1002_mdc3_70089 crossref_primary_10_1016_j_biopha_2025_117903 crossref_primary_10_1016_j_neulet_2025_138334 crossref_primary_10_1097_CM9_0000000000003745 crossref_primary_10_3390_ijms252413260 crossref_primary_10_1111_ejn_16665 crossref_primary_10_3390_ijms26167886 crossref_primary_10_1038_s41531_025_00998_x crossref_primary_10_1186_s13024_025_00837_w crossref_primary_10_3390_ijms25158035 crossref_primary_10_1038_s41531_025_00889_1 crossref_primary_10_1038_s41598_025_00110_6 crossref_primary_10_1016_j_jconrel_2024_11_066 crossref_primary_10_1080_07853890_2025_2452353 crossref_primary_10_1186_s13024_024_00778_w crossref_primary_10_1039_D4QI01945H crossref_primary_10_1177_1877718X251360584 crossref_primary_10_1177_10538127251314727 crossref_primary_10_1016_j_chaos_2024_115635 crossref_primary_10_1111_cns_70076 crossref_primary_10_1016_j_bbi_2025_04_025 crossref_primary_10_1016_j_neuroscience_2025_09_027 crossref_primary_10_1016_j_neures_2024_11_007 crossref_primary_10_2174_0113816128344629250115074105 crossref_primary_10_3389_fnagi_2025_1657349 crossref_primary_10_3390_cimb46050244 crossref_primary_10_1016_j_freeradbiomed_2024_10_281 crossref_primary_10_3390_ijms26031248 crossref_primary_10_1016_j_crtox_2024_100212 crossref_primary_10_3390_brainsci14111147 crossref_primary_10_1098_rsif_2025_0138 crossref_primary_10_4103_NRR_NRR_D_24_01054 crossref_primary_10_1016_j_brainresbull_2024_111165 crossref_primary_10_1016_j_ceca_2025_103049 crossref_primary_10_3389_fphar_2024_1372110 crossref_primary_10_1002_ana_70029 crossref_primary_10_1186_s40001_025_02707_z crossref_primary_10_1002_pro_70190 crossref_primary_10_1016_j_ejmech_2025_117580 crossref_primary_10_1016_j_cclet_2025_111822 crossref_primary_10_3390_biom15020214 crossref_primary_10_1038_s41531_025_01040_w crossref_primary_10_1038_s41598_025_08204_x crossref_primary_10_3390_ijms26125617 crossref_primary_10_1016_j_snb_2025_138331 crossref_primary_10_3390_nano14231962 crossref_primary_10_1186_s12951_025_03354_6 crossref_primary_10_3389_fnagi_2024_1455562 crossref_primary_10_3390_ijms252312842 crossref_primary_10_1007_s12035_025_04810_y crossref_primary_10_1038_s41531_025_01009_9 crossref_primary_10_1186_s12964_024_01965_4 crossref_primary_10_1016_j_ejmech_2025_117597 crossref_primary_10_1016_j_gerinurse_2025_04_004 crossref_primary_10_3390_molecules29225364 crossref_primary_10_1016_j_redox_2025_103787 crossref_primary_10_1016_j_jpha_2024_101102 crossref_primary_10_1016_j_phrs_2024_107168 crossref_primary_10_1002_iub_2936 crossref_primary_10_1002_mds_30321 crossref_primary_10_4103_apjtb_apjtb_229_24 crossref_primary_10_1007_s11064_024_04226_5 crossref_primary_10_3389_fimmu_2025_1652741 crossref_primary_10_3390_ijms26020550 crossref_primary_10_1016_j_snb_2025_137264 crossref_primary_10_1016_j_npep_2025_102563 crossref_primary_10_1016_j_tcb_2025_06_002 crossref_primary_10_3390_ijms252011198 crossref_primary_10_1002_smll_202507517 crossref_primary_10_3389_fncel_2024_1491952 crossref_primary_10_3389_fphar_2025_1539032 crossref_primary_10_4103_NRR_NRR_D_24_01265 crossref_primary_10_1016_j_intimp_2025_114076 crossref_primary_10_1097_MD_0000000000040484 crossref_primary_10_1111_cns_70022 crossref_primary_10_1007_s00415_025_12940_5 crossref_primary_10_3390_biomedicines13071553 crossref_primary_10_1002_hbm_70026 crossref_primary_10_1016_j_cej_2025_164031 crossref_primary_10_1038_s44324_025_00049_2 crossref_primary_10_1016_j_apacoust_2024_110307 crossref_primary_10_1038_s44321_025_00229_z crossref_primary_10_3390_ijms252111532 crossref_primary_10_4103_NRR_NRR_D_24_01371 crossref_primary_10_3389_fmed_2025_1535682 crossref_primary_10_1016_j_bbrc_2025_152078 crossref_primary_10_1080_01616412_2025_2536076 crossref_primary_10_1038_s41531_025_01019_7 crossref_primary_10_1134_S002209302406022X crossref_primary_10_1016_j_freeradbiomed_2025_04_053 crossref_primary_10_1038_s41531_025_01060_6 crossref_primary_10_3390_biomedicines13071585 crossref_primary_10_1016_j_biopha_2025_118282 crossref_primary_10_1111_cns_70250 crossref_primary_10_3390_genes15111397 crossref_primary_10_1016_S0140_6736_23_01419_8 crossref_primary_10_1016_j_neuroscience_2025_08_063 crossref_primary_10_1016_j_brainresbull_2025_111273 crossref_primary_10_1007_s12035_024_04560_3 crossref_primary_10_2217_epi_2023_0416 crossref_primary_10_1016_j_phymed_2025_157067 crossref_primary_10_1080_00207454_2025_2496819 crossref_primary_10_1007_s00415_025_13080_6 crossref_primary_10_1038_s41401_025_01538_2 crossref_primary_10_1038_s41598_024_78132_9 crossref_primary_10_3389_fimmu_2025_1615001 crossref_primary_10_1016_j_freeradbiomed_2025_04_049 crossref_primary_10_1007_s11030_024_11090_6 crossref_primary_10_2147_NDT_S541627 crossref_primary_10_1186_s13024_025_00818_z |
| Cites_doi | 10.1093/brain/awp293 10.1212/01.wnl.0000201252.57661.e1 10.1038/nm1746 10.1038/s41586-019-1405-y 10.1002/ana.24781 10.1212/01.wnl.0000312571.81091.26 10.1042/BST20190236 10.1038/s41531-021-00156-z 10.1093/hmg/ddr358 10.1111/jnc.14808 10.3390/cells11081261 10.1007/s10072-021-05551-1 10.3389/fnagi.2021.648151 10.1001/jamaneurol.2013.172 10.1016/j.nbd.2022.105663 10.1097/00005072-196507000-00003 10.1002/mds.26479 10.1038/s41531-016-0002-0 10.1038/nrneurol.2012.242 10.1093/brain/awab005 10.3233/JPD-223152 10.1016/j.pneurobio.2018.09.003 10.3233/JPD-223228 10.1111/ane.13700 10.1016/S1474-4422(14)70287-X 10.1016/j.pneurobio.2020.101772 10.1038/s41588-021-00847-6 10.1093/brain/awab242 10.1038/s41586-020-2317-6 10.1136/jnnp.51.6.745 10.3233/JPD-191627 10.1093/brain/116.1.281 10.1093/brain/awf086 10.1016/0304-3940(94)90508-8 10.3389/fneur.2018.00815 10.3390/cells9010233 10.1002/mds.27818 10.3389/fcell.2021.612476 10.1016/S1474-4422(23)00205-3 10.1056/NEJMoa2203395 10.1016/S1474-4422(23)00109-6 10.1111/bph.15684 10.1136/jnnp-2020-322857 10.1016/S0140-6736(23)01419-8 10.1016/S1474-4422(09)70238-8 10.3389/fimmu.2018.02122 10.1007/s10072-014-1878-2 10.1016/S0197-4580(02)00065-9 10.1016/j.bbi.2019.06.042 10.1002/mds.28342 10.3390/ijms23073476 10.1126/science.1227157 10.1586/14737175.2016.1135056 10.1016/j.cell.2016.05.039 10.3389/fnins.2022.900338 10.1073/pnas.2020858118 10.1016/j.nbd.2022.105700 10.1016/S1474-4422(21)00061-2 10.1038/nm1747 10.1001/jamaneurol.2016.2742 10.1038/42166 10.1016/S1474-4422(19)30320-5 10.1038/s41531-023-00468-2 10.1126/scitranslmed.aar5429 10.1016/S1353-8020(11)70062-1 10.3389/fneur.2022.764917 10.1038/s41586-020-1984-7 10.1136/bmjopen-2020-040527 10.1093/hmg/ddt554 10.1042/BST20180462 10.1002/mds.29246 10.1007/s10571-021-01039-w 10.1093/brain/awac325 10.3233/JPD-179005 10.1007/s00441-017-2730-9 10.3233/JPD-179006 10.3233/JPD-225111 10.1002/mds.26424 10.1056/NEJMoa2202867 10.1093/brain/awz296 10.1016/j.neuropharm.2022.108964 10.1016/j.celrep.2021.110090 10.1016/S1474-4422(19)30287-X 10.1152/physrev.00041.2021 10.1093/brain/awac414 10.3390/biom11101508 10.3390/cells9112399 10.1001/jamaneurol.2014.2704 10.1016/S1474-4422(15)00144-1 10.1093/brain/awab306 10.1038/s41531-017-0013-5 10.3389/fcell.2021.636506 10.1016/j.neurobiolaging.2021.07.017 10.1038/nature22815 10.1007/s00401-019-02023-x 10.1093/brain/awaa096 10.1002/mds.22727 10.1007/s00415-021-10877-z 10.1136/bmjopen-2020-038911 10.3233/JPD-202138 10.1093/brain/awaa238 10.1212/CPJ.0000000000000702 10.1212/WNL.38.8.1285 10.1016/j.addr.2022.114402 10.1007/s00401-009-0538-8 10.1080/15548627.2021.1888244 10.1002/acn3.580 10.1007/s00401-021-02325-z 10.1038/s41467-020-15626-w 10.1002/mds.26563 10.1042/EBC20210018 10.1002/mds.28685 |
| ContentType | Journal Article |
| Copyright | 2024 Elsevier Ltd Copyright © 2024 Elsevier Ltd. All rights reserved. 2024. Elsevier Ltd |
| Copyright_xml | – notice: 2024 Elsevier Ltd – notice: Copyright © 2024 Elsevier Ltd. All rights reserved. – notice: 2024. Elsevier Ltd |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QL 7QP 7RV 7TK 7U7 7U9 7X7 7XB 88A 88C 88E 88G 88I 8AF 8AO 8C1 8C2 8FE 8FH 8FI 8FJ 8FK 8G5 ABUWG AEUYN AFKRA AN0 ASE AZQEC BBNVY BEC BENPR BHPHI C1K CCPQU DWQXO FPQ FYUFA GHDGH GNUQQ GUQSH H94 HCIFZ K6X K9- K9. KB0 KB~ LK8 M0R M0S M0T M1P M2M M2O M2P M7N M7P MBDVC NAPCQ PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PSYQQ Q9U S0X 7X8 |
| DOI | 10.1016/S0140-6736(23)01478-2 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Bacteriology Abstracts (Microbiology B) Calcium & Calcified Tissue Abstracts Nursing & Allied Health Database Neurosciences Abstracts Toxicology Abstracts Virology and AIDS Abstracts ProQuest Health & Medical Collection ProQuest Central (purchase pre-March 2016) Biology Database (Alumni Edition) Healthcare Administration Database (Alumni) Medical Database (Alumni Edition) Psychology Database (Alumni) Science Database (Alumni Edition) STEM Database ProQuest Pharma Collection ProQuest Public Health Database Lancet Titles ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Research Library (Alumni Edition) ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland British Nursing Database British Nursing Index ProQuest Central Essentials Biological Science Collection eLibrary ProQuest Central ProQuest Natural Science Collection Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Central British Nursing Index (BNI) (1985 to Present) Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student Research Library Prep AIDS and Cancer Research Abstracts SciTech Premium Collection British Nursing Index Consumer Health Database ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) ProQuest Newsstand Professional Biological Sciences Consumer Health Database Health & Medical Collection (Alumni Edition) Healthcare Administration Database Medical Database Psychology Database Research Library Science Database Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Database Research Library (Corporate) Nursing & Allied Health Premium ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest One Psychology ProQuest Central Basic SIRS Editorial MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest One Psychology Research Library Prep ProQuest Central Student ProQuest Central Essentials Lancet Titles elibrary ProQuest AP Science SciTech Premium Collection Environmental Sciences and Pollution Management ProQuest One Applied & Life Sciences ProQuest One Sustainability Health Research Premium Collection Natural Science Collection Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Newsstand Professional Virology and AIDS Abstracts ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest Family Health ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database Neurosciences Abstracts ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest One Academic UKI Edition ProQuest Health Management (Alumni Edition) ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest One Academic (New) ProQuest One Academic Middle East (New) SIRS Editorial ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing Research Library (Alumni Edition) ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Family Health (Alumni Edition) ProQuest Biology Journals (Alumni Edition) ProQuest Central ProQuest Health & Medical Research Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) AIDS and Cancer Research Abstracts ProQuest Research Library ProQuest Public Health ProQuest Central Basic Toxicology Abstracts ProQuest Science Journals British Nursing Index with Full Text ProQuest Health Management British Nursing Index ProQuest Nursing & Allied Health Source ProQuest Psychology Journals (Alumni) ProQuest SciTech Collection ProQuest Medical Library ProQuest Psychology Journals ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | ProQuest One Psychology MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1474-547X |
| EndPage | 304 |
| ExternalDocumentID | 38245249 10_1016_S0140_6736_23_01478_2 S0140673623014782 |
| Genre | Research Support, Non-U.S. Gov't Journal Article Review |
| GrantInformation_xml | – fundername: Parkinson's UK grantid: G-1703 – fundername: Medical Research Council grantid: MR/T018569/1 – fundername: Medical Research Council grantid: MR/Y008219/1 |
| GroupedDBID | --- --K --M .1- .55 .CO .FO 0R~ 123 1B1 1P~ 1RT 1~5 29L 4.4 457 4G. 53G 5VS 7-5 71M 7RV 7X7 88E 88I 8AF 8AO 8C1 8C2 8FE 8FH 8FI 8FJ 8G5 9JM AABNK AAEDT AAEDW AAFWJ AAIKJ AAKOC AALRI AAMRU AAQFI AATTM AAXKI AAXUO AAYWO ABBQC ABCQX ABFNM ABIVO ABJNI ABLJU ABMAC ABMZM ABOCM ABUFD ABUWG ACGFS ACGOD ACIEU ACIUM ACLOT ACPRK ACRLP ACVFH ADBBV ADCNI AEIPS AEKER AENEX AEUPX AEUYN AEVXI AFKRA AFPUW AFRAH AFRHN AFTJW AFXIZ AGAPS AGHFR AHMBA AIGII AIIUN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ AN0 ANZVX APXCP AQUVI AXJTR AZQEC BBNVY BCU BEC BENPR BHPHI BKEYQ BKNYI BKOJK BKOMP BNPGV BNQBC BPHCQ BVXVI CCPQU CS3 DU5 DWQXO EAU EBS EFJIC EFKBS EO8 EO9 EP2 EP3 EWM EX3 F5P FD8 FDB FIRID FNPLU FYGXN FYUFA G-2 G-Q GBLVA GNUQQ GUQSH HCIFZ HMCUK IHE J1W K-O K9- KOM L7B LK8 LZ2 M0R M0T M1P M2M M2O M2P M7P MJL MO0 N9A NAPCQ O-L O9- OD. OO~ OZT P-8 P-9 P2P PC. PHGZM PHGZT PJZUB PPXIY PQGLB PQQKQ PRG PROAC PSQYO PSYQQ ROL RPZ S0X SAD SDG SEL SES SJFOW SJN SPCBC SSH SSZ T5K TLN TWZ UAP UBE UKHRP UV1 WOW X7M XAX XDU YYM Z5R ZMT ~HD AACTN AFCTW ALIPV M41 .GJ 04C 3EH 3O- 41~ 8WZ 9DU A6W AAEJM AAKAS AAQQT AAQXK AAYXX ABDBF ABWVN ACRPL ACUHS ADMUD ADNMO ADXHL ADZCM AFFHD AFFNX AGQPQ AHHHB AHQJS AJJEV AKVCP ARTTT ASPBG AVWKF AZFZN CITATION D0S EAP EAS EAZ EBC EBD EBU EGS EHN EIHBH EJD EMB EMK EMOBN ENC EPL EPS EPT ESX EVS FEDTE FGOYB HVGLF HZ~ J5H MVM OVD Q~Q R2- SV3 TEORI TH9 UHU UQL WOQ WUQ XPP YYQ ZGI ZXP ZY4 ~G0 AGCQF AGRNS CGR CUY CVF ECM EIF NPM 3V. 7QL 7QP 7TK 7U7 7U9 7XB 88A 8FK ASE C1K FPQ H94 K6X K9. KB~ M7N MBDVC PKEHL PQEST PQUKI Q9U 7X8 PUEGO |
| ID | FETCH-LOGICAL-c362t-e9da6a435abfb0ff5d7c405e204306e3e42c44a57ed8401c0668152bd861fb6f3 |
| IEDL.DBID | M7P |
| ISSN | 0140-6736 1474-547X |
| IngestDate | Sat Sep 27 18:42:18 EDT 2025 Tue Oct 07 07:24:49 EDT 2025 Mon Jul 21 05:52:41 EDT 2025 Sat Nov 29 07:23:38 EST 2025 Tue Nov 18 22:39:20 EST 2025 Sun Apr 06 06:53:32 EDT 2025 Tue Oct 14 19:30:49 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 10423 |
| Language | English |
| License | Copyright © 2024 Elsevier Ltd. All rights reserved. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c362t-e9da6a435abfb0ff5d7c405e204306e3e42c44a57ed8401c0668152bd861fb6f3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23 |
| PMID | 38245249 |
| PQID | 2919789133 |
| PQPubID | 40246 |
| PageCount | 12 |
| ParticipantIDs | proquest_miscellaneous_2917551571 proquest_journals_2919789133 pubmed_primary_38245249 crossref_citationtrail_10_1016_S0140_6736_23_01478_2 crossref_primary_10_1016_S0140_6736_23_01478_2 elsevier_sciencedirect_doi_10_1016_S0140_6736_23_01478_2 elsevier_clinicalkey_doi_10_1016_S0140_6736_23_01478_2 |
| PublicationCentury | 2000 |
| PublicationDate | 2024-01-20 |
| PublicationDateYYYYMMDD | 2024-01-20 |
| PublicationDate_xml | – month: 01 year: 2024 text: 2024-01-20 day: 20 |
| PublicationDecade | 2020 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England – name: London |
| PublicationTitle | The Lancet (British edition) |
| PublicationTitleAlternate | Lancet |
| PublicationYear | 2024 |
| Publisher | Elsevier Ltd Elsevier Limited |
| Publisher_xml | – name: Elsevier Ltd – name: Elsevier Limited |
| References | Brooker, Krainc (bib62) 2021; 65 Shahnawaz, Mukherjee, Pritzkow (bib96) 2020; 578 Siderowf, Concha-Marambio, Lafontant (bib98) 2023; 22 Nicoletti, Palermo, Del Prete, Mancuso, Ceravolo (bib49) 2021; 9 Kordower, Chu, Hauser, Freeman, Olanow (bib37) 2008; 14 Alam, Yang, Li (bib83) 2022; 38 Doherty, Silveira-Moriyama, Parkkinen (bib7) 2013; 70 Carling, Mortiboys, Green (bib102) 2020; 187 Gibb, Lees (bib4) 1988; 51 Soutar, Melandri, O’Callaghan (bib20) 2022; 145 Lindestam Arlehamn, Dhanwani, Pham (bib88) 2020; 11 Chen, Hu, Cao, Liu, Cheng (bib111) 2018; 9 Eldeeb, Thomas, Ragheb, Fallahi, Fon (bib54) 2022; 102 Steele, McGeer (bib10) 2008; 70 Erb, Moore (bib66) 2020; 10 Dickson, Braak, Duda (bib34) 2009; 8 Beach, Adler, Lue (bib36) 2009; 117 Mogi, Harada, Kondo (bib69) 1994; 180 Matheoud, Sugiura, Bellemare-Pelletier (bib81) 2016; 166 Luk, Kehm, Carroll (bib39) 2012; 338 Navarro-Romero, Montpeyó, Martinez-Vicente (bib61) 2020; 9 Ben-Shlomo, Darweesh, Llibre-Guerra (bib1) 2024; 403 Schweighauser, Shi, Tarutani (bib29) 2020; 585 McGeer, Itagaki, Boyes, McGeer (bib68) 1988; 38 Weiss, Labrador-Garrido, Dzamko, Halliday (bib76) 2022; 168 Kouli, Horne, Williams-Gray (bib79) 2019; 81 Singh, Ganley (bib56) 2021; 49 Nishioka, Imai, Yoshino, Li, Funayama, Hattori (bib45) 2022; 13 Langston (bib50) 2017; 7 Contaldi, Magistrelli, Comi (bib74) 2022; 12 Ross, Abbott, Petrovitch, Tanner, White (bib43) 2012; 18 Algarni, Stoessl (bib95) 2016; 16 Zhang, Gao (bib110) 2022; 269 Blauwendraat, Nalls, Singleton (bib12) 2020; 19 Qin, Zhang, Cao, Loh, Cheng (bib70) 2016; 73 Burtscher, Syed, Keller, Lashuel, Millet (bib58) 2021; 107 Horowitz, Braunstein, Zimran, Revel-Vilk, Goker-Alpan (bib60) 2022; 187 Kouli, Williams-Gray (bib75) 2022; 12 Rizig, Bandres-Ciga, Makarious (bib19) 2023 Nalls, Blauwendraat, Vallerga (bib22) 2019; 18 Di Maio, Hoffman, Rocha (bib67) 2018; 10 Fan, Nirujogi, Garrido (bib108) 2021; 142 Goedert, Jakes, Spillantini (bib16) 2017; 7 Payne, Sassani, Buckley (bib105) 2020; 10 Tozzi, Sciaccaluga, Loffredo (bib27) 2021; 144 Magistrelli, Contaldi, Vignaroli (bib77) 2022; 23 Spillantini, Schmidt, Lee, Trojanowski, Jakes, Goedert (bib26) 1997; 388 Stefani, Iranzo, Holzknecht (bib97) 2021; 144 Davis, Wong, Carling, Payne, Sue, Bandmann (bib103) 2020; 10 Wang, Feng, Wang (bib55) 2022; 42 Liu, Peng, Liao (bib92) 2021; 53 Scott, Kouli, Yeoh, Clatworthy, Williams-Gray (bib87) 2018; 9 Tan, Lawton, Jabbari (bib91) 2021; 36 Chu, Muller, Tavares (bib42) 2019; 142 Li, Englund, Holton (bib38) 2008; 14 Smith, Schapira (bib64) 2022; 11 Gegg, Menozzi, Schapira (bib13) 2022; 166 Vrijsen, Vrancx, Del Vecchio (bib46) 2022; 16 Giladi, Alcalay, Cutter (bib65) 2023; 22 Vivacqua, Mason, Bartolo (bib99) 2023; 38 Grünewald, Kumar, Sue (bib48) 2019; 177 Haque, Akther, Azam (bib57) 2022; 179 Sulzer, Alcalay, Garretti (bib80) 2017; 546 Braak, Tredici, Rüb, Vos RAI de, Steur, Braak (bib31) 2003; 24 Yang, Shi, Schweighauser (bib25) 2022 Investigators (bib116) 2006; 66 Investigators (bib115) 2015; 14 Arotcarena, Dovero, Prigent (bib41) 2020; 143 Liu, Boot, Locascio (bib89) 2016; 80 Hattingen, Magerkurth, Pilatus (bib104) 2009; 132 Kluss, Mamais, Cookson (bib14) 2019; 47 Singleton, Hardy (bib18) 2011; 20 Merchant, Simuni, Fedler (bib106) 2023; 9 Greenland, Cutting, Kadyan, Bond, Chhabra, Williams-Gray (bib118) 2020; 10 Horsager, Andersen, Knudsen (bib35) 2020; 143 Racette, Gross, Vouri, Camacho-Soto, Willis, Searles Nielsen (bib78) 2018; 5 Holmans, Moskvina, Jones (bib21) 2013; 23 Vijiaratnam, Simuni, Bandmann, Morris, Foltynie (bib2) 2021; 20 Stoker, Camacho, Winder-Rhodes (bib90) 2020; 91 Geddes, Hughes, Lees, Daniel (bib5) 1993; 116 Chahine, Merchant, Siderowf (bib101) 2023; 13 Fan, Tonelli, Padmanabhan (bib109) 2020; 157 Schrag, Horsfall, Walters, Noyce, Petersen (bib33) 2015; 14 Recasens, Ulusoy, Kahle, Di Monte, Dehay (bib40) 2018; 373 Goedert, Spillantini, Del Tredici, Braak (bib17) 2013; 9 Pagano, Taylor, Anzures-Cabrera (bib114) 2022; 387 Alcalay, Hsieh, Tengstrand (bib107) 2020; 35 Xie, Pan, Wang (bib15) 2014; 35 Li, Fu, Halliday, Sue (bib52) 2021; 9 Lang, Siderowf, Macklin (bib113) 2022; 387 Mani, Sevanan, Krishnamoorthy, Sekar (bib51) 2021; 42 Höglinger, Adler, Berg (bib100) 2023 Wang, Xiao, Cui (bib8) 2009; 24 Lobanova, Whiten, Ruggeri (bib30) 2022; 145 Sironi, Restelli, Tolnay, Neutzner, Frank (bib47) 2020; 9 Nissen, Farmen, Carstensen (bib72) 2021 Williams-Gray, Wijeyekoon, Yarnall (bib71) 2016; 31 Caparros-Lefebvre, Sergeant, Lees (bib9) 2002; 125 Kalia, Lang, Hazrati (bib6) 2015; 72 Alam, Bousset, Melki, Otzen (bib32) 2019; 150 Duffy, Tennyson (bib23) 1965; 24 Lewy (bib3) 1912 Real, Martinez-Carrasco, Reynolds (bib93) 2023; 146 Houser, Tansey (bib85) 2017; 3 Bohnen, Hu (bib44) 2019; 9 Morris (bib94) 2022; 146 Farmen, Nissen, Stokholm (bib86) 2021; 118 Terešak, Lapao, Subic, Boya, Elazar, Simonsen (bib53) 2022; 18 Calo, Wegrzynowicz, Santivañez-Perez, Grazia Spillantini (bib28) 2016; 31 Bo, Li, Zhou, Chen, Yuan (bib63) 2022; 207 Romano, Savva, Bedarf, Charles, Hildebrand, Narbad (bib84) 2021; 7 Wegrzynowicz, Bar-On, Calo (bib112) 2019; 138 Postuma, Berg, Stern (bib11) 2015; 30 Matheoud, Cannon, Voisin (bib82) 2019; 571 Muñoz-Delgado, Macías-García, Jesús (bib73) 2021; 36 Gendelman, Zhang, Santamaria (bib117) 2017; 3 Picca, Guerra, Calvani (bib59) 2021; 11 Guo, Sun, Song (bib24) 2021; 13 Calo (10.1016/S0140-6736(23)01478-2_bib28) 2016; 31 Kouli (10.1016/S0140-6736(23)01478-2_bib75) 2022; 12 McGeer (10.1016/S0140-6736(23)01478-2_bib68) 1988; 38 Fan (10.1016/S0140-6736(23)01478-2_bib108) 2021; 142 Zhang (10.1016/S0140-6736(23)01478-2_bib110) 2022; 269 Chu (10.1016/S0140-6736(23)01478-2_bib42) 2019; 142 Bohnen (10.1016/S0140-6736(23)01478-2_bib44) 2019; 9 Arotcarena (10.1016/S0140-6736(23)01478-2_bib41) 2020; 143 Kordower (10.1016/S0140-6736(23)01478-2_bib37) 2008; 14 Alam (10.1016/S0140-6736(23)01478-2_bib32) 2019; 150 Lewy (10.1016/S0140-6736(23)01478-2_bib3) 1912 Houser (10.1016/S0140-6736(23)01478-2_bib85) 2017; 3 Farmen (10.1016/S0140-6736(23)01478-2_bib86) 2021; 118 Gendelman (10.1016/S0140-6736(23)01478-2_bib117) 2017; 3 Tozzi (10.1016/S0140-6736(23)01478-2_bib27) 2021; 144 Weiss (10.1016/S0140-6736(23)01478-2_bib76) 2022; 168 Luk (10.1016/S0140-6736(23)01478-2_bib39) 2012; 338 Picca (10.1016/S0140-6736(23)01478-2_bib59) 2021; 11 Kluss (10.1016/S0140-6736(23)01478-2_bib14) 2019; 47 Recasens (10.1016/S0140-6736(23)01478-2_bib40) 2018; 373 Tan (10.1016/S0140-6736(23)01478-2_bib91) 2021; 36 Fan (10.1016/S0140-6736(23)01478-2_bib109) 2020; 157 Chen (10.1016/S0140-6736(23)01478-2_bib111) 2018; 9 Guo (10.1016/S0140-6736(23)01478-2_bib24) 2021; 13 Sironi (10.1016/S0140-6736(23)01478-2_bib47) 2020; 9 Qin (10.1016/S0140-6736(23)01478-2_bib70) 2016; 73 Ross (10.1016/S0140-6736(23)01478-2_bib43) 2012; 18 Liu (10.1016/S0140-6736(23)01478-2_bib92) 2021; 53 Goedert (10.1016/S0140-6736(23)01478-2_bib16) 2017; 7 Chahine (10.1016/S0140-6736(23)01478-2_bib101) 2023; 13 Vrijsen (10.1016/S0140-6736(23)01478-2_bib46) 2022; 16 Kalia (10.1016/S0140-6736(23)01478-2_bib6) 2015; 72 Magistrelli (10.1016/S0140-6736(23)01478-2_bib77) 2022; 23 Alam (10.1016/S0140-6736(23)01478-2_bib83) 2022; 38 Holmans (10.1016/S0140-6736(23)01478-2_bib21) 2013; 23 Di Maio (10.1016/S0140-6736(23)01478-2_bib67) 2018; 10 Alcalay (10.1016/S0140-6736(23)01478-2_bib107) 2020; 35 Li (10.1016/S0140-6736(23)01478-2_bib52) 2021; 9 Wang (10.1016/S0140-6736(23)01478-2_bib55) 2022; 42 Beach (10.1016/S0140-6736(23)01478-2_bib36) 2009; 117 Matheoud (10.1016/S0140-6736(23)01478-2_bib81) 2016; 166 Greenland (10.1016/S0140-6736(23)01478-2_bib118) 2020; 10 Braak (10.1016/S0140-6736(23)01478-2_bib31) 2003; 24 Postuma (10.1016/S0140-6736(23)01478-2_bib11) 2015; 30 Morris (10.1016/S0140-6736(23)01478-2_bib94) 2022; 146 Payne (10.1016/S0140-6736(23)01478-2_bib105) 2020; 10 Smith (10.1016/S0140-6736(23)01478-2_bib64) 2022; 11 Gibb (10.1016/S0140-6736(23)01478-2_bib4) 1988; 51 Hattingen (10.1016/S0140-6736(23)01478-2_bib104) 2009; 132 Pagano (10.1016/S0140-6736(23)01478-2_bib114) 2022; 387 Brooker (10.1016/S0140-6736(23)01478-2_bib62) 2021; 65 Geddes (10.1016/S0140-6736(23)01478-2_bib5) 1993; 116 Yang (10.1016/S0140-6736(23)01478-2_bib25) 2022 Stoker (10.1016/S0140-6736(23)01478-2_bib90) 2020; 91 Siderowf (10.1016/S0140-6736(23)01478-2_bib98) 2023; 22 Scott (10.1016/S0140-6736(23)01478-2_bib87) 2018; 9 Caparros-Lefebvre (10.1016/S0140-6736(23)01478-2_bib9) 2002; 125 Williams-Gray (10.1016/S0140-6736(23)01478-2_bib71) 2016; 31 Real (10.1016/S0140-6736(23)01478-2_bib93) 2023; 146 Racette (10.1016/S0140-6736(23)01478-2_bib78) 2018; 5 Vijiaratnam (10.1016/S0140-6736(23)01478-2_bib2) 2021; 20 Langston (10.1016/S0140-6736(23)01478-2_bib50) 2017; 7 Stefani (10.1016/S0140-6736(23)01478-2_bib97) 2021; 144 Kouli (10.1016/S0140-6736(23)01478-2_bib79) 2019; 81 Investigators (10.1016/S0140-6736(23)01478-2_bib116) 2006; 66 Investigators (10.1016/S0140-6736(23)01478-2_bib115) 2015; 14 Horowitz (10.1016/S0140-6736(23)01478-2_bib60) 2022; 187 Terešak (10.1016/S0140-6736(23)01478-2_bib53) 2022; 18 Carling (10.1016/S0140-6736(23)01478-2_bib102) 2020; 187 Nalls (10.1016/S0140-6736(23)01478-2_bib22) 2019; 18 Bo (10.1016/S0140-6736(23)01478-2_bib63) 2022; 207 Goedert (10.1016/S0140-6736(23)01478-2_bib17) 2013; 9 Singleton (10.1016/S0140-6736(23)01478-2_bib18) 2011; 20 Shahnawaz (10.1016/S0140-6736(23)01478-2_bib96) 2020; 578 Merchant (10.1016/S0140-6736(23)01478-2_bib106) 2023; 9 Duffy (10.1016/S0140-6736(23)01478-2_bib23) 1965; 24 Mani (10.1016/S0140-6736(23)01478-2_bib51) 2021; 42 Lindestam Arlehamn (10.1016/S0140-6736(23)01478-2_bib88) 2020; 11 Li (10.1016/S0140-6736(23)01478-2_bib38) 2008; 14 Davis (10.1016/S0140-6736(23)01478-2_bib103) 2020; 10 Eldeeb (10.1016/S0140-6736(23)01478-2_bib54) 2022; 102 Haque (10.1016/S0140-6736(23)01478-2_bib57) 2022; 179 Blauwendraat (10.1016/S0140-6736(23)01478-2_bib12) 2020; 19 Muñoz-Delgado (10.1016/S0140-6736(23)01478-2_bib73) 2021; 36 Matheoud (10.1016/S0140-6736(23)01478-2_bib82) 2019; 571 Singh (10.1016/S0140-6736(23)01478-2_bib56) 2021; 49 Wegrzynowicz (10.1016/S0140-6736(23)01478-2_bib112) 2019; 138 Nishioka (10.1016/S0140-6736(23)01478-2_bib45) 2022; 13 Wang (10.1016/S0140-6736(23)01478-2_bib8) 2009; 24 Grünewald (10.1016/S0140-6736(23)01478-2_bib48) 2019; 177 Mogi (10.1016/S0140-6736(23)01478-2_bib69) 1994; 180 Steele (10.1016/S0140-6736(23)01478-2_bib10) 2008; 70 Spillantini (10.1016/S0140-6736(23)01478-2_bib26) 1997; 388 Schrag (10.1016/S0140-6736(23)01478-2_bib33) 2015; 14 Erb (10.1016/S0140-6736(23)01478-2_bib66) 2020; 10 Gegg (10.1016/S0140-6736(23)01478-2_bib13) 2022; 166 Liu (10.1016/S0140-6736(23)01478-2_bib89) 2016; 80 Algarni (10.1016/S0140-6736(23)01478-2_bib95) 2016; 16 Vivacqua (10.1016/S0140-6736(23)01478-2_bib99) 2023; 38 Horsager (10.1016/S0140-6736(23)01478-2_bib35) 2020; 143 Nicoletti (10.1016/S0140-6736(23)01478-2_bib49) 2021; 9 Höglinger (10.1016/S0140-6736(23)01478-2_bib100) 2023 Soutar (10.1016/S0140-6736(23)01478-2_bib20) 2022; 145 Burtscher (10.1016/S0140-6736(23)01478-2_bib58) 2021; 107 Lang (10.1016/S0140-6736(23)01478-2_bib113) 2022; 387 Doherty (10.1016/S0140-6736(23)01478-2_bib7) 2013; 70 Xie (10.1016/S0140-6736(23)01478-2_bib15) 2014; 35 Rizig (10.1016/S0140-6736(23)01478-2_bib19) 2023 Navarro-Romero (10.1016/S0140-6736(23)01478-2_bib61) 2020; 9 Nissen (10.1016/S0140-6736(23)01478-2_bib72) 2021 Dickson (10.1016/S0140-6736(23)01478-2_bib34) 2009; 8 Lobanova (10.1016/S0140-6736(23)01478-2_bib30) 2022; 145 Contaldi (10.1016/S0140-6736(23)01478-2_bib74) 2022; 12 Ben-Shlomo (10.1016/S0140-6736(23)01478-2_bib1) 2024; 403 Schweighauser (10.1016/S0140-6736(23)01478-2_bib29) 2020; 585 Sulzer (10.1016/S0140-6736(23)01478-2_bib80) 2017; 546 Giladi (10.1016/S0140-6736(23)01478-2_bib65) 2023; 22 Romano (10.1016/S0140-6736(23)01478-2_bib84) 2021; 7 |
| References_xml | – volume: 9 start-page: 13 year: 2013 end-page: 24 ident: bib17 article-title: 100 years of Lewy pathology publication-title: Nat Rev Neurol – volume: 14 start-page: 57 year: 2015 end-page: 64 ident: bib33 article-title: Prediagnostic presentations of Parkinson's disease in primary care: a case-control study publication-title: Lancet Neurol – volume: 65 start-page: 873 year: 2021 end-page: 883 ident: bib62 article-title: Glucocerebrosidase dysfunction in neurodegenerative disease publication-title: Essays Biochem – volume: 42 start-page: 4459 year: 2021 end-page: 4469 ident: bib51 article-title: A systematic review of molecular approaches that link mitochondrial dysfunction and neuroinflammation in Parkinson's disease publication-title: Neurol Sci – volume: 80 start-page: 674 year: 2016 end-page: 685 ident: bib89 article-title: Specifically neuropathic Gaucher's mutations accelerate cognitive decline in Parkinson's publication-title: Ann Neurol – volume: 10 start-page: e040527 year: 2020 ident: bib118 article-title: Azathioprine immunosuppression and disease modification in Parkinson's disease (AZA-PD): a randomised double-blind placebo-controlled phase II trial protocol publication-title: BMJ Open – volume: 7 start-page: S51 year: 2017 end-page: S69 ident: bib16 article-title: The synucleinopathies: twenty years on. publication-title: J Parkinsons Dis – volume: 10 start-page: e038911 year: 2020 ident: bib105 article-title: Ursodeoxycholic acid as a novel disease-modifying treatment for Parkinson's disease: protocol for a two-centre, randomised, double-blind, placebo-controlled trial, the ‘UP’ study publication-title: BMJ Open – volume: 16 start-page: 900338 year: 2022 ident: bib46 article-title: Inter-organellar communication in Parkinson's and Alzheimer's disease: looking beyond endoplasmic reticulum-mitochondria contact sites publication-title: Front Neurosci – volume: 102 start-page: 1721 year: 2022 end-page: 1755 ident: bib54 article-title: Mitochondrial quality control in health and in Parkinson's disease publication-title: Physiol Rev – volume: 166 start-page: 105663 year: 2022 ident: bib13 article-title: Glucocerebrosidase-associated Parkinson disease: pathogenic mechanisms and potential drug treatments publication-title: Neurobiol Dis – volume: 8 start-page: 1150 year: 2009 end-page: 1157 ident: bib34 article-title: Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria publication-title: Lancet Neurol – volume: 23 start-page: 3476 year: 2022 ident: bib77 article-title: Immune response modifications in the genetic forms of Parkinson's disease: what do we know? publication-title: Int J Mol Sci – volume: 14 start-page: 501 year: 2008 end-page: 503 ident: bib38 article-title: Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation publication-title: Nat Med – volume: 7 start-page: 27 year: 2021 ident: bib84 article-title: Meta-analysis of the Parkinson's disease gut microbiome suggests alterations linked to intestinal inflammation publication-title: NPJ Parkinsons Dis – year: 2021 ident: bib72 article-title: Changes in CD163+, CD11b+, and CCR2+ peripheral monocytes relate to Parkinson's disease and cognition. publication-title: medRxiv – volume: 387 start-page: 408 year: 2022 end-page: 420 ident: bib113 article-title: Trial of cinpanemab in early Parkinson's disease publication-title: N Engl J Med – volume: 23 start-page: 562 year: 2013 ident: bib21 article-title: A pathway-based analysis provides additional support for an immune-related genetic susceptibility to Parkinson's disease publication-title: Hum Mol Genet – volume: 10 start-page: eaar5429 year: 2018 ident: bib67 article-title: LRRK2 activation in idiopathic Parkinson's disease publication-title: Sci Transl Med – volume: 70 start-page: 571 year: 2013 end-page: 579 ident: bib7 article-title: Parkin disease: a clinicopathologic entity? publication-title: JAMA Neurol – volume: 51 start-page: 745 year: 1988 end-page: 752 ident: bib4 article-title: The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease publication-title: J Neurol Neurosurg Psychiatry – volume: 143 start-page: 1462 year: 2020 end-page: 1475 ident: bib41 article-title: Bidirectional gut-to-brain and brain-to-gut propagation of synucleinopathy in non-human primates publication-title: Brain – volume: 24 start-page: 197 year: 2003 end-page: 211 ident: bib31 article-title: Staging of brain pathology related to sporadic Parkinson's disease publication-title: Neurobiol Aging – volume: 168 start-page: 105700 year: 2022 ident: bib76 article-title: Immune responses in the Parkinson's disease brain publication-title: Neurobiol Dis – volume: 24 start-page: 398 year: 1965 end-page: 414 ident: bib23 article-title: Phase and electron microscopic observations of Lewy bodies and melanin granules in the substantia nigra and locus caeruleus in Parkinson's disease publication-title: J Neuropathol Exp Neurol – volume: 138 start-page: 575 year: 2019 end-page: 595 ident: bib112 article-title: Depopulation of dense α-synuclein aggregates is associated with rescue of dopamine neuron dysfunction and death in a new Parkinson's disease model publication-title: Acta Neuropathol – volume: 9 start-page: 603 year: 2019 end-page: 614 ident: bib44 article-title: Sleep disturbance as potential risk and progression factor for Parkinson's disease publication-title: J Parkinsons Dis – volume: 47 start-page: 651 year: 2019 end-page: 661 ident: bib14 article-title: LRRK2 links genetic and sporadic Parkinson's disease publication-title: Biochem Soc Trans – volume: 9 start-page: 612476 year: 2021 ident: bib52 article-title: genes link mitochondrial dysfunction and alpha-synuclein pathology in sporadic Parkinson's disease publication-title: Front Cell Dev Biol – volume: 12 start-page: S65 year: 2022 end-page: S74 ident: bib74 article-title: T lymphocytes in Parkinson's disease publication-title: J Parkinsons Dis – volume: 42 start-page: 1321 year: 2022 end-page: 1339 ident: bib55 article-title: Mitophagy, a form of selective autophagy, plays an essential role in mitochondrial dynamics of Parkinson's disease publication-title: Cell Mol Neurobiol – volume: 373 start-page: 183 year: 2018 end-page: 193 ident: bib40 article-title: In vivo models of alpha-synuclein transmission and propagation publication-title: Cell Tissue Res – volume: 157 start-page: e58956 year: 2020 ident: bib109 article-title: Human peripheral blood neutrophil isolation for interrogating the Parkinson's associated LRRK2 kinase pathway by assessing Rab10 phosphorylation publication-title: J Vis Exp – volume: 38 start-page: 1285 year: 1988 end-page: 1291 ident: bib68 article-title: Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains publication-title: Neurology – start-page: 920 year: 1912 end-page: 933 ident: bib3 article-title: Paralysis agitans. I. Pathologische anatomie publication-title: Handbuch der Neurologie – volume: 146 start-page: 1873 year: 2023 end-page: 1887 ident: bib93 article-title: Association between the LRP1B and APOE loci and the development of Parkinson's disease dementia publication-title: Brain – volume: 388 start-page: 839 year: 1997 end-page: 840 ident: bib26 article-title: α-Synuclein in Lewy bodies publication-title: Nature – volume: 118 year: 2021 ident: bib86 article-title: Monocyte markers correlate with immune and neuronal brain changes in REM sleep behavior disorder publication-title: Proc Natl Acad Sci USA – volume: 7 start-page: S11 year: 2017 end-page: S19 ident: bib50 article-title: The MPTP story publication-title: J Parkinsons Dis – volume: 9 start-page: 2399 year: 2020 ident: bib61 article-title: The emerging role of the lysosome in Parkinson's disease publication-title: Cells – volume: 81 start-page: 41 year: 2019 end-page: 51 ident: bib79 article-title: Toll-like receptors and their therapeutic potential in Parkinson's disease and α-synucleinopathies publication-title: Brain Behav Immun – volume: 19 start-page: 170 year: 2020 end-page: 178 ident: bib12 article-title: The genetic architecture of Parkinson's disease publication-title: Lancet Neurol – volume: 179 start-page: 23 year: 2022 end-page: 45 ident: bib57 article-title: Targeting α-synuclein aggregation and its role in mitochondrial dysfunction in Parkinson's disease publication-title: Br J Pharmacol – volume: 35 start-page: 1495 year: 2014 end-page: 1504 ident: bib15 article-title: The association between the LRRK2 G2385R variant and the risk of Parkinson's disease: a meta-analysis based on 23 case-control studies publication-title: Neurol Sci – volume: 18 start-page: S199 year: 2012 end-page: S202 ident: bib43 article-title: Pre-motor features of Parkinson's disease: the Honolulu-Asia Aging Study experience. publication-title: Parkinsonism Relat Disord – volume: 11 start-page: 1875 year: 2020 ident: bib88 article-title: α-Synuclein-specific T cell reactivity is associated with preclinical and early Parkinson's disease publication-title: Nat Commun – volume: 20 start-page: 559 year: 2021 end-page: 572 ident: bib2 article-title: Progress towards therapies for disease modification in Parkinson's disease publication-title: Lancet Neurol – volume: 142 start-page: 3565 year: 2019 end-page: 3579 ident: bib42 article-title: Intrastriatal alpha-synuclein fibrils in monkeys: spreading, imaging and neuropathological changes publication-title: Brain – volume: 13 start-page: 297 year: 2023 end-page: 309 ident: bib101 article-title: Proposal for a biologic staging system of Parkinson's disease publication-title: J Parkinsons Dis – volume: 117 start-page: 613 year: 2009 end-page: 634 ident: bib36 article-title: Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction publication-title: Acta Neuropathol – volume: 20 start-page: R158 year: 2011 end-page: R162 ident: bib18 article-title: A generalizable hypothesis for the genetic architecture of disease: pleomorphic risk loci publication-title: Hum Mol Genet – volume: 10 start-page: 40 year: 2020 end-page: 46 ident: bib103 article-title: Serum FGF-21, GDF-15, and blood mtDNA copy number are not biomarkers of Parkinson disease publication-title: Neurol Clin Pract – volume: 144 start-page: 3477 year: 2021 end-page: 3491 ident: bib27 article-title: Dopamine-dependent early synaptic and motor dysfunctions induced by α-synuclein in the nigrostriatal circuit publication-title: Brain – volume: 9 start-page: 2122 year: 2018 ident: bib111 article-title: Cerebrospinal fluid inflammatory cytokine aberrations in Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis: a systematic review and meta-analysis publication-title: Front Immunol – volume: 5 start-page: 870 year: 2018 end-page: 875 ident: bib78 article-title: Immunosuppressants and risk of Parkinson disease publication-title: Ann Clin Transl Neurol – volume: 585 start-page: 464 year: 2020 end-page: 469 ident: bib29 article-title: Structures of α-synuclein filaments from multiple system atrophy publication-title: Nature – volume: 13 start-page: 764917 year: 2022 ident: bib45 article-title: Clinical manifestations and molecular backgrounds of Parkinson's Disease regarding genes identified from familial and population studies publication-title: Front Neurol – volume: 73 start-page: 1316 year: 2016 end-page: 1324 ident: bib70 article-title: Aberrations in peripheral inflammatory cytokine levels in Parkinson disease: a systematic review and meta-analysis publication-title: JAMA Neurol – volume: 3 start-page: 3 year: 2017 ident: bib85 article-title: The gut-brain axis: is intestinal inflammation a silent driver of Parkinson's disease pathogenesis? publication-title: NPJ Parkinsons Dis – volume: 35 start-page: 134 year: 2020 end-page: 141 ident: bib107 article-title: Higher urine bis(monoacylglycerol)phosphate levels in LRRK2 G2019S mutation carriers: implications for therapeutic development publication-title: Mov Disord – volume: 38 start-page: 110090 year: 2022 ident: bib83 article-title: Alpha synuclein, the culprit in Parkinson disease, is required for normal immune function publication-title: Cell Rep – volume: 10 start-page: 1271 year: 2020 end-page: 1291 ident: bib66 article-title: LRRK2 and the endolysosomal system in Parkinson's disease publication-title: J Parkinsons Dis – volume: 14 start-page: 795 year: 2015 end-page: 803 ident: bib115 article-title: Pioglitazone in early Parkinson's disease: a phase 2, multicentre, double-blind, randomised trial publication-title: Lancet Neurol – volume: 11 start-page: 1508 year: 2021 ident: bib59 article-title: Mitochondrial dysfunction, protein misfolding and neuroinflammation in Parkinson's disease: roads to biomarker discovery publication-title: Biomolecules – volume: 125 start-page: 801 year: 2002 end-page: 811 ident: bib9 article-title: Guadeloupean parkinsonism: a cluster of progressive supranuclear palsy-like tauopathy publication-title: Brain – volume: 24 start-page: 2007 year: 2009 end-page: 2011 ident: bib8 article-title: Analysis of SCA2 and SCA3/MJD repeats in Parkinson's disease in mainland China: genetic, clinical, and positron emission tomography findings publication-title: Mov Disord – volume: 91 start-page: 695 year: 2020 end-page: 702 ident: bib90 article-title: Impact of publication-title: J Neurol Neurosurg Psychiatry – volume: 269 start-page: 2304 year: 2022 end-page: 2314 ident: bib110 article-title: Neuroinflammation in Parkinson's disease: a meta-analysis of PET imaging studies publication-title: J Neurol – volume: 14 start-page: 504 year: 2008 end-page: 506 ident: bib37 article-title: Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease publication-title: Nat Med – volume: 107 start-page: 128 year: 2021 end-page: 141 ident: bib58 article-title: Fatal attraction - the role of hypoxia when alpha-synuclein gets intimate with mitochondria publication-title: Neurobiol Aging – volume: 177 start-page: 73 year: 2019 end-page: 93 ident: bib48 article-title: New insights into the complex role of mitochondria in Parkinson's disease publication-title: Prog Neurobiol – volume: 150 start-page: 522 year: 2019 end-page: 534 ident: bib32 article-title: α-Synuclein oligomers and fibrils: a spectrum of species, a spectrum of toxicities publication-title: J Neurochem – volume: 207 start-page: 108964 year: 2022 ident: bib63 article-title: The neuroinflammatory role of glucocerebrosidase in Parkinson's disease publication-title: Neuropharmacology – year: 2023 ident: bib100 article-title: Towards a biological definition of Parkinson's disease. publication-title: Preprints – volume: 132 start-page: 3285 year: 2009 end-page: 3297 ident: bib104 article-title: Phosphorus and proton magnetic resonance spectroscopy demonstrates mitochondrial dysfunction in early and advanced Parkinson's disease publication-title: Brain – volume: 38 start-page: 153 year: 2023 end-page: 155 ident: bib99 article-title: Salivary α-synuclein RT-QuIC correlates with disease severity in de novo Parkinson's disease publication-title: Mov Disord – volume: 145 start-page: 4349 year: 2022 end-page: 4367 ident: bib20 article-title: Regulation of mitophagy by the NSL complex underlies genetic risk for Parkinson's disease at 16q11.2 and MAPT H1 loci publication-title: Brain – volume: 571 start-page: 565 year: 2019 end-page: 569 ident: bib82 article-title: Intestinal infection triggers Parkinson's disease-like symptoms in Pink1 publication-title: Nature – volume: 144 start-page: 1118 year: 2021 end-page: 1126 ident: bib97 article-title: Alpha-synuclein seeds in olfactory mucosa of patients with isolated REM sleep behaviour disorder publication-title: Brain – volume: 180 start-page: 147 year: 1994 end-page: 150 ident: bib69 article-title: Interleukin-1 β, interleukin-6, epidermal growth factor and transforming growth factor-α are elevated in the brain from parkinsonian patients publication-title: Neurosci Lett – volume: 30 start-page: 1591 year: 2015 end-page: 1601 ident: bib11 article-title: MDS clinical diagnostic criteria for Parkinson's disease publication-title: Mov Disord – volume: 22 start-page: 407 year: 2023 end-page: 417 ident: bib98 article-title: Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional study publication-title: Lancet Neurol – volume: 31 start-page: 995 year: 2016 end-page: 1003 ident: bib71 article-title: Serum immune markers and disease progression in an incident Parkinson's disease cohort (ICICLE-PD) publication-title: Mov Disord – year: 2022 ident: bib25 article-title: Cryo-EM structures of α-synuclein filaments from Parkinson's disease and dementia with Lewy bodies. publication-title: bioRxiv – volume: 18 start-page: 24 year: 2022 end-page: 39 ident: bib53 article-title: Regulation of PRKN-independent mitophagy publication-title: Autophagy – volume: 31 start-page: 169 year: 2016 end-page: 177 ident: bib28 article-title: Synaptic failure and α-synuclein publication-title: Mov Disord – year: 2023 ident: bib19 article-title: Genome-wide association identifies novel etiological insights associated with Parkinson's disease in African and African admixed populations. publication-title: medRxiv – volume: 578 start-page: 273 year: 2020 end-page: 277 ident: bib96 article-title: Discriminating α-synuclein strains in Parkinson's disease and multiple system atrophy publication-title: Nature – volume: 166 start-page: 314 year: 2016 end-page: 327 ident: bib81 article-title: Parkinson's disease-related proteins PINK1 and parkin repress mitochondrial antigen presentation publication-title: Cell – volume: 9 start-page: 30 year: 2023 ident: bib106 article-title: LRRK2 and GBA1 variant carriers have higher urinary bis(monacylglycerol) phosphate concentrations in PPMI cohorts publication-title: NPJ Parkinsons Dis – volume: 18 start-page: 1091 year: 2019 end-page: 1102 ident: bib22 article-title: Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies publication-title: Lancet Neurol – volume: 142 start-page: 475 year: 2021 end-page: 494 ident: bib108 article-title: R1441G but not G2019S mutation enhances LRRK2 mediated Rab10 phosphorylation in human peripheral blood neutrophils publication-title: Acta Neuropathol – volume: 16 start-page: 187 year: 2016 end-page: 203 ident: bib95 article-title: The role of biomarkers and imaging in Parkinson's disease publication-title: Expert Rev Neurother – volume: 116 start-page: 281 year: 1993 end-page: 302 ident: bib5 article-title: Pathological overlap in cases of parkinsonism associated with neurofibrillary tangles. A study of recent cases of postencephalitic parkinsonism and comparison with progressive supranuclear palsy and Guamanian parkinsonism-dementia complex publication-title: Brain – volume: 12 start-page: S93 year: 2022 end-page: 104 ident: bib75 article-title: Age-related adaptive immune changes in Parkinson's disease publication-title: J Parkinsons Dis – volume: 53 start-page: 787 year: 2021 end-page: 793 ident: bib92 article-title: Genome-wide survival study identifies a novel synaptic locus and polygenic score for cognitive progression in Parkinson's disease publication-title: Nat Genet – volume: 546 start-page: 656 year: 2017 end-page: 661 ident: bib80 article-title: T cells from patients with Parkinson's disease recognize α-synuclein peptides publication-title: Nature – volume: 187 start-page: 114402 year: 2022 ident: bib60 article-title: Lysosomal functions and dysfunctions: molecular and cellular mechanisms underlying Gaucher disease and its association with Parkinson disease publication-title: Adv Drug Deliv Rev – volume: 403 start-page: 293 year: 2024 end-page: 3-4 ident: bib1 article-title: The epidemiology of Parkinson's disease publication-title: Lancet – volume: 70 start-page: 1984 year: 2008 end-page: 1990 ident: bib10 article-title: The ALS/PDC syndrome of Guam and the cycad hypothesis publication-title: Neurology – volume: 36 start-page: 2426 year: 2021 end-page: 2430 ident: bib73 article-title: Peripheral immune profile and neutrophil-to-lymphocyte ratio in Parkinson's disease publication-title: Mov Disord – volume: 387 start-page: 421 year: 2022 end-page: 432 ident: bib114 article-title: Trial of prasinezumab in early-stage Parkinson's disease publication-title: N Engl J Med – volume: 9 start-page: 636506 year: 2021 ident: bib49 article-title: Understanding the multiple role of mitochondria in Parkinson's disease and related disorders: lesson from genetics and protein-interaction network publication-title: Front Cell Dev Biol – volume: 143 start-page: 3077 year: 2020 end-page: 3088 ident: bib35 article-title: Brain-first versus body-first Parkinson's disease: a multimodal imaging case-control study publication-title: Brain – volume: 11 start-page: 1261 year: 2022 ident: bib64 article-title: variants and Parkinson disease: mechanisms and treatments publication-title: Cells – volume: 72 start-page: 100 year: 2015 end-page: 105 ident: bib6 article-title: Clinical correlations with Lewy body pathology in LRRK2-related Parkinson disease publication-title: JAMA Neurol – volume: 338 start-page: 949 year: 2012 end-page: 953 ident: bib39 article-title: Pathological α-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice publication-title: Science – volume: 9 start-page: 233 year: 2020 ident: bib47 article-title: Dysregulated interorganellar crosstalk of mitochondria in the pathogenesis of Parkinson's disease publication-title: Cells – volume: 9 start-page: 815 year: 2018 ident: bib87 article-title: A systematic review and meta-analysis of alpha synuclein auto-antibodies in Parkinson's disease publication-title: Front Neurol – volume: 3 start-page: 10 year: 2017 ident: bib117 article-title: Evaluation of the safety and immunomodulatory effects of sargramostim in a randomized, double-blind phase 1 clinical Parkinson's disease trial publication-title: NPJ Parkinsons Dis – volume: 66 start-page: 664 year: 2006 end-page: 671 ident: bib116 article-title: A randomized, double-blind, futility clinical trial of creatine and minocycline in early Parkinson disease publication-title: Neurology – volume: 36 start-page: 424 year: 2021 end-page: 433 ident: bib91 article-title: Genome-wide association studies of cognitive and motor progression in Parkinson's disease publication-title: Mov Disord – volume: 49 start-page: 551 year: 2021 end-page: 562 ident: bib56 article-title: Parkinson's disease and mitophagy: an emerging role for LRRK2 publication-title: Biochem Soc Trans – volume: 13 start-page: 648151 year: 2021 ident: bib24 article-title: Genetic analysis and literature review of publication-title: Front Aging Neurosci – volume: 187 start-page: 101772 year: 2020 ident: bib102 article-title: Deep phenotyping of peripheral tissue facilitates mechanistic disease stratification in sporadic Parkinson's disease publication-title: Prog Neurobiol – volume: 145 start-page: 632 year: 2022 end-page: 643 ident: bib30 article-title: Imaging protein aggregates in the serum and cerebrospinal fluid in Parkinson's disease publication-title: Brain – volume: 22 start-page: 661 year: 2023 end-page: 671 ident: bib65 article-title: Safety and efficacy of venglustat in GBA1-associated Parkinson's disease: an international, multicentre, double-blind, randomised, placebo-controlled, phase 2 trial publication-title: Lancet Neurol – volume: 146 start-page: 353 year: 2022 end-page: 361 ident: bib94 article-title: Blood based biomarkers for movement disorders publication-title: Acta Neurol Scand – volume: 132 start-page: 3285 year: 2009 ident: 10.1016/S0140-6736(23)01478-2_bib104 article-title: Phosphorus and proton magnetic resonance spectroscopy demonstrates mitochondrial dysfunction in early and advanced Parkinson's disease publication-title: Brain doi: 10.1093/brain/awp293 – volume: 66 start-page: 664 year: 2006 ident: 10.1016/S0140-6736(23)01478-2_bib116 article-title: A randomized, double-blind, futility clinical trial of creatine and minocycline in early Parkinson disease publication-title: Neurology doi: 10.1212/01.wnl.0000201252.57661.e1 – volume: 14 start-page: 501 year: 2008 ident: 10.1016/S0140-6736(23)01478-2_bib38 article-title: Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation publication-title: Nat Med doi: 10.1038/nm1746 – volume: 571 start-page: 565 year: 2019 ident: 10.1016/S0140-6736(23)01478-2_bib82 article-title: Intestinal infection triggers Parkinson's disease-like symptoms in Pink1-/- mice publication-title: Nature doi: 10.1038/s41586-019-1405-y – volume: 80 start-page: 674 year: 2016 ident: 10.1016/S0140-6736(23)01478-2_bib89 article-title: Specifically neuropathic Gaucher's mutations accelerate cognitive decline in Parkinson's publication-title: Ann Neurol doi: 10.1002/ana.24781 – volume: 70 start-page: 1984 year: 2008 ident: 10.1016/S0140-6736(23)01478-2_bib10 article-title: The ALS/PDC syndrome of Guam and the cycad hypothesis publication-title: Neurology doi: 10.1212/01.wnl.0000312571.81091.26 – volume: 49 start-page: 551 year: 2021 ident: 10.1016/S0140-6736(23)01478-2_bib56 article-title: Parkinson's disease and mitophagy: an emerging role for LRRK2 publication-title: Biochem Soc Trans doi: 10.1042/BST20190236 – volume: 7 start-page: 27 year: 2021 ident: 10.1016/S0140-6736(23)01478-2_bib84 article-title: Meta-analysis of the Parkinson's disease gut microbiome suggests alterations linked to intestinal inflammation publication-title: NPJ Parkinsons Dis doi: 10.1038/s41531-021-00156-z – volume: 20 start-page: R158 year: 2011 ident: 10.1016/S0140-6736(23)01478-2_bib18 article-title: A generalizable hypothesis for the genetic architecture of disease: pleomorphic risk loci publication-title: Hum Mol Genet doi: 10.1093/hmg/ddr358 – volume: 150 start-page: 522 year: 2019 ident: 10.1016/S0140-6736(23)01478-2_bib32 article-title: α-Synuclein oligomers and fibrils: a spectrum of species, a spectrum of toxicities publication-title: J Neurochem doi: 10.1111/jnc.14808 – volume: 11 start-page: 1261 year: 2022 ident: 10.1016/S0140-6736(23)01478-2_bib64 article-title: GBA variants and Parkinson disease: mechanisms and treatments publication-title: Cells doi: 10.3390/cells11081261 – volume: 42 start-page: 4459 year: 2021 ident: 10.1016/S0140-6736(23)01478-2_bib51 article-title: A systematic review of molecular approaches that link mitochondrial dysfunction and neuroinflammation in Parkinson's disease publication-title: Neurol Sci doi: 10.1007/s10072-021-05551-1 – volume: 13 start-page: 648151 year: 2021 ident: 10.1016/S0140-6736(23)01478-2_bib24 article-title: Genetic analysis and literature review of SNCA variants in Parkinson's disease publication-title: Front Aging Neurosci doi: 10.3389/fnagi.2021.648151 – volume: 70 start-page: 571 year: 2013 ident: 10.1016/S0140-6736(23)01478-2_bib7 article-title: Parkin disease: a clinicopathologic entity? publication-title: JAMA Neurol doi: 10.1001/jamaneurol.2013.172 – volume: 166 start-page: 105663 year: 2022 ident: 10.1016/S0140-6736(23)01478-2_bib13 article-title: Glucocerebrosidase-associated Parkinson disease: pathogenic mechanisms and potential drug treatments publication-title: Neurobiol Dis doi: 10.1016/j.nbd.2022.105663 – volume: 24 start-page: 398 year: 1965 ident: 10.1016/S0140-6736(23)01478-2_bib23 article-title: Phase and electron microscopic observations of Lewy bodies and melanin granules in the substantia nigra and locus caeruleus in Parkinson's disease publication-title: J Neuropathol Exp Neurol doi: 10.1097/00005072-196507000-00003 – volume: 31 start-page: 169 year: 2016 ident: 10.1016/S0140-6736(23)01478-2_bib28 article-title: Synaptic failure and α-synuclein publication-title: Mov Disord doi: 10.1002/mds.26479 – volume: 3 start-page: 3 year: 2017 ident: 10.1016/S0140-6736(23)01478-2_bib85 article-title: The gut-brain axis: is intestinal inflammation a silent driver of Parkinson's disease pathogenesis? publication-title: NPJ Parkinsons Dis doi: 10.1038/s41531-016-0002-0 – volume: 9 start-page: 13 year: 2013 ident: 10.1016/S0140-6736(23)01478-2_bib17 article-title: 100 years of Lewy pathology publication-title: Nat Rev Neurol doi: 10.1038/nrneurol.2012.242 – volume: 144 start-page: 1118 year: 2021 ident: 10.1016/S0140-6736(23)01478-2_bib97 article-title: Alpha-synuclein seeds in olfactory mucosa of patients with isolated REM sleep behaviour disorder publication-title: Brain doi: 10.1093/brain/awab005 – volume: 12 start-page: S65 year: 2022 ident: 10.1016/S0140-6736(23)01478-2_bib74 article-title: T lymphocytes in Parkinson's disease publication-title: J Parkinsons Dis doi: 10.3233/JPD-223152 – volume: 177 start-page: 73 year: 2019 ident: 10.1016/S0140-6736(23)01478-2_bib48 article-title: New insights into the complex role of mitochondria in Parkinson's disease publication-title: Prog Neurobiol doi: 10.1016/j.pneurobio.2018.09.003 – volume: 12 start-page: S93 year: 2022 ident: 10.1016/S0140-6736(23)01478-2_bib75 article-title: Age-related adaptive immune changes in Parkinson's disease publication-title: J Parkinsons Dis doi: 10.3233/JPD-223228 – volume: 146 start-page: 353 year: 2022 ident: 10.1016/S0140-6736(23)01478-2_bib94 article-title: Blood based biomarkers for movement disorders publication-title: Acta Neurol Scand doi: 10.1111/ane.13700 – volume: 14 start-page: 57 year: 2015 ident: 10.1016/S0140-6736(23)01478-2_bib33 article-title: Prediagnostic presentations of Parkinson's disease in primary care: a case-control study publication-title: Lancet Neurol doi: 10.1016/S1474-4422(14)70287-X – volume: 187 start-page: 101772 year: 2020 ident: 10.1016/S0140-6736(23)01478-2_bib102 article-title: Deep phenotyping of peripheral tissue facilitates mechanistic disease stratification in sporadic Parkinson's disease publication-title: Prog Neurobiol doi: 10.1016/j.pneurobio.2020.101772 – volume: 53 start-page: 787 year: 2021 ident: 10.1016/S0140-6736(23)01478-2_bib92 article-title: Genome-wide survival study identifies a novel synaptic locus and polygenic score for cognitive progression in Parkinson's disease publication-title: Nat Genet doi: 10.1038/s41588-021-00847-6 – volume: 144 start-page: 3477 year: 2021 ident: 10.1016/S0140-6736(23)01478-2_bib27 article-title: Dopamine-dependent early synaptic and motor dysfunctions induced by α-synuclein in the nigrostriatal circuit publication-title: Brain doi: 10.1093/brain/awab242 – volume: 585 start-page: 464 year: 2020 ident: 10.1016/S0140-6736(23)01478-2_bib29 article-title: Structures of α-synuclein filaments from multiple system atrophy publication-title: Nature doi: 10.1038/s41586-020-2317-6 – volume: 51 start-page: 745 year: 1988 ident: 10.1016/S0140-6736(23)01478-2_bib4 article-title: The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease publication-title: J Neurol Neurosurg Psychiatry doi: 10.1136/jnnp.51.6.745 – volume: 9 start-page: 603 year: 2019 ident: 10.1016/S0140-6736(23)01478-2_bib44 article-title: Sleep disturbance as potential risk and progression factor for Parkinson's disease publication-title: J Parkinsons Dis doi: 10.3233/JPD-191627 – volume: 116 start-page: 281 year: 1993 ident: 10.1016/S0140-6736(23)01478-2_bib5 article-title: Pathological overlap in cases of parkinsonism associated with neurofibrillary tangles. A study of recent cases of postencephalitic parkinsonism and comparison with progressive supranuclear palsy and Guamanian parkinsonism-dementia complex publication-title: Brain doi: 10.1093/brain/116.1.281 – volume: 125 start-page: 801 year: 2002 ident: 10.1016/S0140-6736(23)01478-2_bib9 article-title: Guadeloupean parkinsonism: a cluster of progressive supranuclear palsy-like tauopathy publication-title: Brain doi: 10.1093/brain/awf086 – volume: 180 start-page: 147 year: 1994 ident: 10.1016/S0140-6736(23)01478-2_bib69 article-title: Interleukin-1 β, interleukin-6, epidermal growth factor and transforming growth factor-α are elevated in the brain from parkinsonian patients publication-title: Neurosci Lett doi: 10.1016/0304-3940(94)90508-8 – year: 2023 ident: 10.1016/S0140-6736(23)01478-2_bib19 article-title: Genome-wide association identifies novel etiological insights associated with Parkinson's disease in African and African admixed populations. publication-title: medRxiv – volume: 9 start-page: 815 year: 2018 ident: 10.1016/S0140-6736(23)01478-2_bib87 article-title: A systematic review and meta-analysis of alpha synuclein auto-antibodies in Parkinson's disease publication-title: Front Neurol doi: 10.3389/fneur.2018.00815 – volume: 9 start-page: 233 year: 2020 ident: 10.1016/S0140-6736(23)01478-2_bib47 article-title: Dysregulated interorganellar crosstalk of mitochondria in the pathogenesis of Parkinson's disease publication-title: Cells doi: 10.3390/cells9010233 – volume: 35 start-page: 134 year: 2020 ident: 10.1016/S0140-6736(23)01478-2_bib107 article-title: Higher urine bis(monoacylglycerol)phosphate levels in LRRK2 G2019S mutation carriers: implications for therapeutic development publication-title: Mov Disord doi: 10.1002/mds.27818 – volume: 9 start-page: 612476 year: 2021 ident: 10.1016/S0140-6736(23)01478-2_bib52 article-title: PARK genes link mitochondrial dysfunction and alpha-synuclein pathology in sporadic Parkinson's disease publication-title: Front Cell Dev Biol doi: 10.3389/fcell.2021.612476 – volume: 22 start-page: 661 year: 2023 ident: 10.1016/S0140-6736(23)01478-2_bib65 article-title: Safety and efficacy of venglustat in GBA1-associated Parkinson's disease: an international, multicentre, double-blind, randomised, placebo-controlled, phase 2 trial publication-title: Lancet Neurol doi: 10.1016/S1474-4422(23)00205-3 – year: 2023 ident: 10.1016/S0140-6736(23)01478-2_bib100 article-title: Towards a biological definition of Parkinson's disease. publication-title: Preprints – volume: 387 start-page: 408 year: 2022 ident: 10.1016/S0140-6736(23)01478-2_bib113 article-title: Trial of cinpanemab in early Parkinson's disease publication-title: N Engl J Med doi: 10.1056/NEJMoa2203395 – volume: 22 start-page: 407 year: 2023 ident: 10.1016/S0140-6736(23)01478-2_bib98 article-title: Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional study publication-title: Lancet Neurol doi: 10.1016/S1474-4422(23)00109-6 – volume: 179 start-page: 23 year: 2022 ident: 10.1016/S0140-6736(23)01478-2_bib57 article-title: Targeting α-synuclein aggregation and its role in mitochondrial dysfunction in Parkinson's disease publication-title: Br J Pharmacol doi: 10.1111/bph.15684 – year: 2021 ident: 10.1016/S0140-6736(23)01478-2_bib72 article-title: Changes in CD163+, CD11b+, and CCR2+ peripheral monocytes relate to Parkinson's disease and cognition. publication-title: medRxiv – volume: 91 start-page: 695 year: 2020 ident: 10.1016/S0140-6736(23)01478-2_bib90 article-title: Impact of GBA1 variants on long-term clinical progression and mortality in incident Parkinson's disease publication-title: J Neurol Neurosurg Psychiatry doi: 10.1136/jnnp-2020-322857 – volume: 403 start-page: 293 year: 2024 ident: 10.1016/S0140-6736(23)01478-2_bib1 article-title: The epidemiology of Parkinson's disease publication-title: Lancet doi: 10.1016/S0140-6736(23)01419-8 – year: 2022 ident: 10.1016/S0140-6736(23)01478-2_bib25 article-title: Cryo-EM structures of α-synuclein filaments from Parkinson's disease and dementia with Lewy bodies. publication-title: bioRxiv – volume: 8 start-page: 1150 year: 2009 ident: 10.1016/S0140-6736(23)01478-2_bib34 article-title: Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria publication-title: Lancet Neurol doi: 10.1016/S1474-4422(09)70238-8 – volume: 9 start-page: 2122 year: 2018 ident: 10.1016/S0140-6736(23)01478-2_bib111 article-title: Cerebrospinal fluid inflammatory cytokine aberrations in Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis: a systematic review and meta-analysis publication-title: Front Immunol doi: 10.3389/fimmu.2018.02122 – volume: 35 start-page: 1495 year: 2014 ident: 10.1016/S0140-6736(23)01478-2_bib15 article-title: The association between the LRRK2 G2385R variant and the risk of Parkinson's disease: a meta-analysis based on 23 case-control studies publication-title: Neurol Sci doi: 10.1007/s10072-014-1878-2 – volume: 24 start-page: 197 year: 2003 ident: 10.1016/S0140-6736(23)01478-2_bib31 article-title: Staging of brain pathology related to sporadic Parkinson's disease publication-title: Neurobiol Aging doi: 10.1016/S0197-4580(02)00065-9 – volume: 81 start-page: 41 year: 2019 ident: 10.1016/S0140-6736(23)01478-2_bib79 article-title: Toll-like receptors and their therapeutic potential in Parkinson's disease and α-synucleinopathies publication-title: Brain Behav Immun doi: 10.1016/j.bbi.2019.06.042 – volume: 36 start-page: 424 year: 2021 ident: 10.1016/S0140-6736(23)01478-2_bib91 article-title: Genome-wide association studies of cognitive and motor progression in Parkinson's disease publication-title: Mov Disord doi: 10.1002/mds.28342 – volume: 23 start-page: 3476 year: 2022 ident: 10.1016/S0140-6736(23)01478-2_bib77 article-title: Immune response modifications in the genetic forms of Parkinson's disease: what do we know? publication-title: Int J Mol Sci doi: 10.3390/ijms23073476 – volume: 338 start-page: 949 year: 2012 ident: 10.1016/S0140-6736(23)01478-2_bib39 article-title: Pathological α-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice publication-title: Science doi: 10.1126/science.1227157 – volume: 16 start-page: 187 year: 2016 ident: 10.1016/S0140-6736(23)01478-2_bib95 article-title: The role of biomarkers and imaging in Parkinson's disease publication-title: Expert Rev Neurother doi: 10.1586/14737175.2016.1135056 – volume: 166 start-page: 314 year: 2016 ident: 10.1016/S0140-6736(23)01478-2_bib81 article-title: Parkinson's disease-related proteins PINK1 and parkin repress mitochondrial antigen presentation publication-title: Cell doi: 10.1016/j.cell.2016.05.039 – volume: 16 start-page: 900338 year: 2022 ident: 10.1016/S0140-6736(23)01478-2_bib46 article-title: Inter-organellar communication in Parkinson's and Alzheimer's disease: looking beyond endoplasmic reticulum-mitochondria contact sites publication-title: Front Neurosci doi: 10.3389/fnins.2022.900338 – volume: 118 year: 2021 ident: 10.1016/S0140-6736(23)01478-2_bib86 article-title: Monocyte markers correlate with immune and neuronal brain changes in REM sleep behavior disorder publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.2020858118 – volume: 168 start-page: 105700 year: 2022 ident: 10.1016/S0140-6736(23)01478-2_bib76 article-title: Immune responses in the Parkinson's disease brain publication-title: Neurobiol Dis doi: 10.1016/j.nbd.2022.105700 – volume: 20 start-page: 559 year: 2021 ident: 10.1016/S0140-6736(23)01478-2_bib2 article-title: Progress towards therapies for disease modification in Parkinson's disease publication-title: Lancet Neurol doi: 10.1016/S1474-4422(21)00061-2 – volume: 14 start-page: 504 year: 2008 ident: 10.1016/S0140-6736(23)01478-2_bib37 article-title: Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease publication-title: Nat Med doi: 10.1038/nm1747 – volume: 73 start-page: 1316 year: 2016 ident: 10.1016/S0140-6736(23)01478-2_bib70 article-title: Aberrations in peripheral inflammatory cytokine levels in Parkinson disease: a systematic review and meta-analysis publication-title: JAMA Neurol doi: 10.1001/jamaneurol.2016.2742 – volume: 388 start-page: 839 year: 1997 ident: 10.1016/S0140-6736(23)01478-2_bib26 article-title: α-Synuclein in Lewy bodies publication-title: Nature doi: 10.1038/42166 – volume: 18 start-page: 1091 year: 2019 ident: 10.1016/S0140-6736(23)01478-2_bib22 article-title: Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies publication-title: Lancet Neurol doi: 10.1016/S1474-4422(19)30320-5 – volume: 9 start-page: 30 year: 2023 ident: 10.1016/S0140-6736(23)01478-2_bib106 article-title: LRRK2 and GBA1 variant carriers have higher urinary bis(monacylglycerol) phosphate concentrations in PPMI cohorts publication-title: NPJ Parkinsons Dis doi: 10.1038/s41531-023-00468-2 – volume: 10 start-page: eaar5429 year: 2018 ident: 10.1016/S0140-6736(23)01478-2_bib67 article-title: LRRK2 activation in idiopathic Parkinson's disease publication-title: Sci Transl Med doi: 10.1126/scitranslmed.aar5429 – volume: 18 start-page: S199 issue: suppl 1 year: 2012 ident: 10.1016/S0140-6736(23)01478-2_bib43 article-title: Pre-motor features of Parkinson's disease: the Honolulu-Asia Aging Study experience. publication-title: Parkinsonism Relat Disord doi: 10.1016/S1353-8020(11)70062-1 – volume: 13 start-page: 764917 year: 2022 ident: 10.1016/S0140-6736(23)01478-2_bib45 article-title: Clinical manifestations and molecular backgrounds of Parkinson's Disease regarding genes identified from familial and population studies publication-title: Front Neurol doi: 10.3389/fneur.2022.764917 – volume: 578 start-page: 273 year: 2020 ident: 10.1016/S0140-6736(23)01478-2_bib96 article-title: Discriminating α-synuclein strains in Parkinson's disease and multiple system atrophy publication-title: Nature doi: 10.1038/s41586-020-1984-7 – volume: 10 start-page: e040527 year: 2020 ident: 10.1016/S0140-6736(23)01478-2_bib118 article-title: Azathioprine immunosuppression and disease modification in Parkinson's disease (AZA-PD): a randomised double-blind placebo-controlled phase II trial protocol publication-title: BMJ Open doi: 10.1136/bmjopen-2020-040527 – volume: 23 start-page: 562 year: 2013 ident: 10.1016/S0140-6736(23)01478-2_bib21 article-title: A pathway-based analysis provides additional support for an immune-related genetic susceptibility to Parkinson's disease publication-title: Hum Mol Genet doi: 10.1093/hmg/ddt554 – volume: 47 start-page: 651 year: 2019 ident: 10.1016/S0140-6736(23)01478-2_bib14 article-title: LRRK2 links genetic and sporadic Parkinson's disease publication-title: Biochem Soc Trans doi: 10.1042/BST20180462 – volume: 38 start-page: 153 year: 2023 ident: 10.1016/S0140-6736(23)01478-2_bib99 article-title: Salivary α-synuclein RT-QuIC correlates with disease severity in de novo Parkinson's disease publication-title: Mov Disord doi: 10.1002/mds.29246 – volume: 42 start-page: 1321 year: 2022 ident: 10.1016/S0140-6736(23)01478-2_bib55 article-title: Mitophagy, a form of selective autophagy, plays an essential role in mitochondrial dynamics of Parkinson's disease publication-title: Cell Mol Neurobiol doi: 10.1007/s10571-021-01039-w – volume: 145 start-page: 4349 year: 2022 ident: 10.1016/S0140-6736(23)01478-2_bib20 article-title: Regulation of mitophagy by the NSL complex underlies genetic risk for Parkinson's disease at 16q11.2 and MAPT H1 loci publication-title: Brain doi: 10.1093/brain/awac325 – volume: 7 start-page: S51 issue: suppl 1 year: 2017 ident: 10.1016/S0140-6736(23)01478-2_bib16 article-title: The synucleinopathies: twenty years on. publication-title: J Parkinsons Dis doi: 10.3233/JPD-179005 – volume: 373 start-page: 183 year: 2018 ident: 10.1016/S0140-6736(23)01478-2_bib40 article-title: In vivo models of alpha-synuclein transmission and propagation publication-title: Cell Tissue Res doi: 10.1007/s00441-017-2730-9 – volume: 7 start-page: S11 year: 2017 ident: 10.1016/S0140-6736(23)01478-2_bib50 article-title: The MPTP story publication-title: J Parkinsons Dis doi: 10.3233/JPD-179006 – volume: 13 start-page: 297 year: 2023 ident: 10.1016/S0140-6736(23)01478-2_bib101 article-title: Proposal for a biologic staging system of Parkinson's disease publication-title: J Parkinsons Dis doi: 10.3233/JPD-225111 – start-page: 920 year: 1912 ident: 10.1016/S0140-6736(23)01478-2_bib3 article-title: Paralysis agitans. I. Pathologische anatomie – volume: 30 start-page: 1591 year: 2015 ident: 10.1016/S0140-6736(23)01478-2_bib11 article-title: MDS clinical diagnostic criteria for Parkinson's disease publication-title: Mov Disord doi: 10.1002/mds.26424 – volume: 387 start-page: 421 year: 2022 ident: 10.1016/S0140-6736(23)01478-2_bib114 article-title: Trial of prasinezumab in early-stage Parkinson's disease publication-title: N Engl J Med doi: 10.1056/NEJMoa2202867 – volume: 142 start-page: 3565 year: 2019 ident: 10.1016/S0140-6736(23)01478-2_bib42 article-title: Intrastriatal alpha-synuclein fibrils in monkeys: spreading, imaging and neuropathological changes publication-title: Brain doi: 10.1093/brain/awz296 – volume: 207 start-page: 108964 year: 2022 ident: 10.1016/S0140-6736(23)01478-2_bib63 article-title: The neuroinflammatory role of glucocerebrosidase in Parkinson's disease publication-title: Neuropharmacology doi: 10.1016/j.neuropharm.2022.108964 – volume: 38 start-page: 110090 year: 2022 ident: 10.1016/S0140-6736(23)01478-2_bib83 article-title: Alpha synuclein, the culprit in Parkinson disease, is required for normal immune function publication-title: Cell Rep doi: 10.1016/j.celrep.2021.110090 – volume: 19 start-page: 170 year: 2020 ident: 10.1016/S0140-6736(23)01478-2_bib12 article-title: The genetic architecture of Parkinson's disease publication-title: Lancet Neurol doi: 10.1016/S1474-4422(19)30287-X – volume: 102 start-page: 1721 year: 2022 ident: 10.1016/S0140-6736(23)01478-2_bib54 article-title: Mitochondrial quality control in health and in Parkinson's disease publication-title: Physiol Rev doi: 10.1152/physrev.00041.2021 – volume: 146 start-page: 1873 year: 2023 ident: 10.1016/S0140-6736(23)01478-2_bib93 article-title: Association between the LRP1B and APOE loci and the development of Parkinson's disease dementia publication-title: Brain doi: 10.1093/brain/awac414 – volume: 11 start-page: 1508 year: 2021 ident: 10.1016/S0140-6736(23)01478-2_bib59 article-title: Mitochondrial dysfunction, protein misfolding and neuroinflammation in Parkinson's disease: roads to biomarker discovery publication-title: Biomolecules doi: 10.3390/biom11101508 – volume: 9 start-page: 2399 year: 2020 ident: 10.1016/S0140-6736(23)01478-2_bib61 article-title: The emerging role of the lysosome in Parkinson's disease publication-title: Cells doi: 10.3390/cells9112399 – volume: 157 start-page: e58956 year: 2020 ident: 10.1016/S0140-6736(23)01478-2_bib109 article-title: Human peripheral blood neutrophil isolation for interrogating the Parkinson's associated LRRK2 kinase pathway by assessing Rab10 phosphorylation publication-title: J Vis Exp – volume: 72 start-page: 100 year: 2015 ident: 10.1016/S0140-6736(23)01478-2_bib6 article-title: Clinical correlations with Lewy body pathology in LRRK2-related Parkinson disease publication-title: JAMA Neurol doi: 10.1001/jamaneurol.2014.2704 – volume: 14 start-page: 795 year: 2015 ident: 10.1016/S0140-6736(23)01478-2_bib115 article-title: Pioglitazone in early Parkinson's disease: a phase 2, multicentre, double-blind, randomised trial publication-title: Lancet Neurol doi: 10.1016/S1474-4422(15)00144-1 – volume: 145 start-page: 632 year: 2022 ident: 10.1016/S0140-6736(23)01478-2_bib30 article-title: Imaging protein aggregates in the serum and cerebrospinal fluid in Parkinson's disease publication-title: Brain doi: 10.1093/brain/awab306 – volume: 3 start-page: 10 year: 2017 ident: 10.1016/S0140-6736(23)01478-2_bib117 article-title: Evaluation of the safety and immunomodulatory effects of sargramostim in a randomized, double-blind phase 1 clinical Parkinson's disease trial publication-title: NPJ Parkinsons Dis doi: 10.1038/s41531-017-0013-5 – volume: 9 start-page: 636506 year: 2021 ident: 10.1016/S0140-6736(23)01478-2_bib49 article-title: Understanding the multiple role of mitochondria in Parkinson's disease and related disorders: lesson from genetics and protein-interaction network publication-title: Front Cell Dev Biol doi: 10.3389/fcell.2021.636506 – volume: 107 start-page: 128 year: 2021 ident: 10.1016/S0140-6736(23)01478-2_bib58 article-title: Fatal attraction - the role of hypoxia when alpha-synuclein gets intimate with mitochondria publication-title: Neurobiol Aging doi: 10.1016/j.neurobiolaging.2021.07.017 – volume: 546 start-page: 656 year: 2017 ident: 10.1016/S0140-6736(23)01478-2_bib80 article-title: T cells from patients with Parkinson's disease recognize α-synuclein peptides publication-title: Nature doi: 10.1038/nature22815 – volume: 138 start-page: 575 year: 2019 ident: 10.1016/S0140-6736(23)01478-2_bib112 article-title: Depopulation of dense α-synuclein aggregates is associated with rescue of dopamine neuron dysfunction and death in a new Parkinson's disease model publication-title: Acta Neuropathol doi: 10.1007/s00401-019-02023-x – volume: 143 start-page: 1462 year: 2020 ident: 10.1016/S0140-6736(23)01478-2_bib41 article-title: Bidirectional gut-to-brain and brain-to-gut propagation of synucleinopathy in non-human primates publication-title: Brain doi: 10.1093/brain/awaa096 – volume: 24 start-page: 2007 year: 2009 ident: 10.1016/S0140-6736(23)01478-2_bib8 article-title: Analysis of SCA2 and SCA3/MJD repeats in Parkinson's disease in mainland China: genetic, clinical, and positron emission tomography findings publication-title: Mov Disord doi: 10.1002/mds.22727 – volume: 269 start-page: 2304 year: 2022 ident: 10.1016/S0140-6736(23)01478-2_bib110 article-title: Neuroinflammation in Parkinson's disease: a meta-analysis of PET imaging studies publication-title: J Neurol doi: 10.1007/s00415-021-10877-z – volume: 10 start-page: e038911 year: 2020 ident: 10.1016/S0140-6736(23)01478-2_bib105 article-title: Ursodeoxycholic acid as a novel disease-modifying treatment for Parkinson's disease: protocol for a two-centre, randomised, double-blind, placebo-controlled trial, the ‘UP’ study publication-title: BMJ Open doi: 10.1136/bmjopen-2020-038911 – volume: 10 start-page: 1271 year: 2020 ident: 10.1016/S0140-6736(23)01478-2_bib66 article-title: LRRK2 and the endolysosomal system in Parkinson's disease publication-title: J Parkinsons Dis doi: 10.3233/JPD-202138 – volume: 143 start-page: 3077 year: 2020 ident: 10.1016/S0140-6736(23)01478-2_bib35 article-title: Brain-first versus body-first Parkinson's disease: a multimodal imaging case-control study publication-title: Brain doi: 10.1093/brain/awaa238 – volume: 10 start-page: 40 year: 2020 ident: 10.1016/S0140-6736(23)01478-2_bib103 article-title: Serum FGF-21, GDF-15, and blood mtDNA copy number are not biomarkers of Parkinson disease publication-title: Neurol Clin Pract doi: 10.1212/CPJ.0000000000000702 – volume: 38 start-page: 1285 year: 1988 ident: 10.1016/S0140-6736(23)01478-2_bib68 article-title: Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains publication-title: Neurology doi: 10.1212/WNL.38.8.1285 – volume: 187 start-page: 114402 year: 2022 ident: 10.1016/S0140-6736(23)01478-2_bib60 article-title: Lysosomal functions and dysfunctions: molecular and cellular mechanisms underlying Gaucher disease and its association with Parkinson disease publication-title: Adv Drug Deliv Rev doi: 10.1016/j.addr.2022.114402 – volume: 117 start-page: 613 year: 2009 ident: 10.1016/S0140-6736(23)01478-2_bib36 article-title: Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction publication-title: Acta Neuropathol doi: 10.1007/s00401-009-0538-8 – volume: 18 start-page: 24 year: 2022 ident: 10.1016/S0140-6736(23)01478-2_bib53 article-title: Regulation of PRKN-independent mitophagy publication-title: Autophagy doi: 10.1080/15548627.2021.1888244 – volume: 5 start-page: 870 year: 2018 ident: 10.1016/S0140-6736(23)01478-2_bib78 article-title: Immunosuppressants and risk of Parkinson disease publication-title: Ann Clin Transl Neurol doi: 10.1002/acn3.580 – volume: 142 start-page: 475 year: 2021 ident: 10.1016/S0140-6736(23)01478-2_bib108 article-title: R1441G but not G2019S mutation enhances LRRK2 mediated Rab10 phosphorylation in human peripheral blood neutrophils publication-title: Acta Neuropathol doi: 10.1007/s00401-021-02325-z – volume: 11 start-page: 1875 year: 2020 ident: 10.1016/S0140-6736(23)01478-2_bib88 article-title: α-Synuclein-specific T cell reactivity is associated with preclinical and early Parkinson's disease publication-title: Nat Commun doi: 10.1038/s41467-020-15626-w – volume: 31 start-page: 995 year: 2016 ident: 10.1016/S0140-6736(23)01478-2_bib71 article-title: Serum immune markers and disease progression in an incident Parkinson's disease cohort (ICICLE-PD) publication-title: Mov Disord doi: 10.1002/mds.26563 – volume: 65 start-page: 873 year: 2021 ident: 10.1016/S0140-6736(23)01478-2_bib62 article-title: Glucocerebrosidase dysfunction in neurodegenerative disease publication-title: Essays Biochem doi: 10.1042/EBC20210018 – volume: 36 start-page: 2426 year: 2021 ident: 10.1016/S0140-6736(23)01478-2_bib73 article-title: Peripheral immune profile and neutrophil-to-lymphocyte ratio in Parkinson's disease publication-title: Mov Disord doi: 10.1002/mds.28685 |
| SSID | ssj0004605 |
| Score | 2.7576487 |
| SecondaryResourceType | review_article |
| Snippet | Parkinson's disease is a progressive neurodegenerative condition associated with the deposition of aggregated α-synuclein. Insights into the pathogenesis of... Summary Parkinson's disease is a progressive neurodegenerative condition associated with the deposition of aggregated α-synuclein. Insights into the... |
| SourceID | proquest pubmed crossref elsevier |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 293 |
| SubjectTerms | Aggregates alpha-Synuclein - metabolism Alzheimer's disease Animal diseases Animal models Animals Atrophy Biomarkers Brain Brain - pathology Brain stem Dementia Gene loci Genetics Genomes Humans Inflammation Models, Animal Movement disorders Mutation Neurodegenerative diseases Neurons Neuropathology Neuroprotection Parkinson Disease - etiology Parkinson Disease - therapy Parkinson's disease Pathogenesis Pathology Proteins Synuclein |
| Title | The pathogenesis of Parkinson's disease |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0140673623014782 https://dx.doi.org/10.1016/S0140-6736(23)01478-2 https://www.ncbi.nlm.nih.gov/pubmed/38245249 https://www.proquest.com/docview/2919789133 https://www.proquest.com/docview/2917551571 |
| Volume | 403 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVPQU databaseName: Biological Science Database customDbUrl: eissn: 1474-547X dateEnd: 20250909 omitProxy: false ssIdentifier: ssj0004605 issn: 0140-6736 databaseCode: M7P dateStart: 19920104 isFulltext: true titleUrlDefault: http://search.proquest.com/biologicalscijournals providerName: ProQuest – providerCode: PRVPQU databaseName: Consumer Health Database customDbUrl: eissn: 1474-547X dateEnd: 20250909 omitProxy: false ssIdentifier: ssj0004605 issn: 0140-6736 databaseCode: M0R dateStart: 19920104 isFulltext: true titleUrlDefault: https://search.proquest.com/familyhealth providerName: ProQuest – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1474-547X dateEnd: 20250909 omitProxy: false ssIdentifier: ssj0004605 issn: 0140-6736 databaseCode: 7X7 dateStart: 19920104 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: Healthcare Administration Database customDbUrl: eissn: 1474-547X dateEnd: 20250909 omitProxy: false ssIdentifier: ssj0004605 issn: 0140-6736 databaseCode: M0T dateStart: 19920104 isFulltext: true titleUrlDefault: https://search.proquest.com/healthmanagement providerName: ProQuest – providerCode: PRVPQU databaseName: Nursing & Allied Health Database customDbUrl: eissn: 1474-547X dateEnd: 20250909 omitProxy: false ssIdentifier: ssj0004605 issn: 0140-6736 databaseCode: 7RV dateStart: 19920104 isFulltext: true titleUrlDefault: https://search.proquest.com/nahs providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1474-547X dateEnd: 20250909 omitProxy: false ssIdentifier: ssj0004605 issn: 0140-6736 databaseCode: BENPR dateStart: 19920104 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Proquest Research Library customDbUrl: eissn: 1474-547X dateEnd: 20250909 omitProxy: false ssIdentifier: ssj0004605 issn: 0140-6736 databaseCode: M2O dateStart: 19920104 isFulltext: true titleUrlDefault: https://search.proquest.com/pqrl providerName: ProQuest – providerCode: PRVPQU databaseName: Psychology Database customDbUrl: eissn: 1474-547X dateEnd: 20250909 omitProxy: false ssIdentifier: ssj0004605 issn: 0140-6736 databaseCode: M2M dateStart: 19920104 isFulltext: true titleUrlDefault: https://www.proquest.com/psychology providerName: ProQuest – providerCode: PRVPQU databaseName: Public Health Database customDbUrl: eissn: 1474-547X dateEnd: 20250909 omitProxy: false ssIdentifier: ssj0004605 issn: 0140-6736 databaseCode: 8C1 dateStart: 19920104 isFulltext: true titleUrlDefault: https://search.proquest.com/publichealth providerName: ProQuest – providerCode: PRVPQU databaseName: Science Database customDbUrl: eissn: 1474-547X dateEnd: 20250909 omitProxy: false ssIdentifier: ssj0004605 issn: 0140-6736 databaseCode: M2P dateStart: 19920104 isFulltext: true titleUrlDefault: https://search.proquest.com/sciencejournals providerName: ProQuest |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1JS8NAFH5oFfHivtSlRBCqh2gymWZmTqKieLC11IXewiSZiCBNNdXf75vJJF7cwMuDSfJCMtv73rwNYJ8KyhLuSdeTmefSTPiuDOPA9UOp0397gSwDha9Zr8eHQ9G3B26Fdaus9kSzUad5os_Ij4nwUeERqFKdjF9cXTVKW1dtCY1pmNFZEgLjutf_Ki7SuLh_RvAc39YXD0hwiA1Upsh3suk77Glk0OXif79-CRYs-nROy-myDFNqtAJzXWtfX4U2zhpHFynOH_Ue-FQ4eebowGgTI9YuHGvPWYP7y4u78yvXllJwE5RQE1eJVIYSoZGMs9jLsk7KEoRqSkfGeqEKFCUJpbLDVIoan58gEOEo2eOUh34Wh1mwDo1RPlKb4EjkF4qFLEZowKSKaRoLnwtFpdJJRptAq06MEptnXJe7eI6-cCgjQWT6PiJNOKrZxmWijd8YwmqEoiqKFPe9CEXBb4y8ZrQwo4QPf2HdqYY3smu9iD7Htgl79W1cpdr0IkcqfzPPMMSmHeY3YaOcQvVfBlxbv6nY-vnl2zBPEFDp4x_i7UBj8vqmdmE2eZ88Fa8tmGaDB02HzFCOlJ_7LZg5u-j1B9jqeiW905R0Db0xtN8yy-YDJzILXQ |
| linkProvider | ProQuest |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3JTsMwEB2VRcCFfSkUCBIIOIQmjhvHB4QQi0C0FRJF6s04iYMqoQZIAfFTfCPjbFzYLhw4Zpkoicczb-x5MwCblFMWeJY0LRlZJo24bUrXd0zblbr8t-XIjCjcZO221-3yywq8FVwYnVZZ2MTUUIdxoNfI64TbGPBwDKkO7h9M3TVK764WLTQytbhQry8YsiX758c4vluEnJ50js7MvKuAGaCxHpiKh9KViBKkH_lWFDVCFiBqUZokarnKUZQElMoGUyEGP3aAPtlDJ-eHnmtHvhs5-NwhGNF19XQKYcvqfMbDTFPqPxhD9avy5A5xdvEAgzfylS_8CuumPu906r_9rWmYzNG1cZhNhxmoqP4sjLXy_IE52MZZYegmzPGttvG9xIgjQxO_Uw7cdmLk-1XzcP0nr7kAw_24r5bAkCjPFXOZj9CHSeXT0Oe2xxWVShdRrQItBk0EeR113c7jTnySMEcckY61IFXYK8Xus0IiPwm4hUaIgiWLdl2gq_tJ0CsFcxiVwaPfiNYKdRK5LUvEhy5VYaO8jFZIby3Jvoqf0nsYYu8Gs6uwmKls-ZWOp3f3KV_-_uHrMH7WaTVF87x9sQITBMGjXuoiVg2GB49PahVGg-dBL3lcSyedATd_rbfvs6decQ |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1LS8QwEB7WB-LF92N11QqKeqjbptmmOYiIuijqIqjgLaZtIguyVbsq_jV_nZO-vPi6ePDYx5S2mcx8k5kvA7BGOWVR4EjbkdqxqeauLf3Qs11fmu2_HU_mROFT1ukE19f8vAZvJRfGlFWWNjEz1HESmTXyJuEuBjwcQ6qmLsoizg_au_cPtukgZTKtZTuNXEVO1OsLhm_pzvEBjvU6Ie3Dy_0ju-gwYEdouPu24rH0JSIGGerQ0boVswgRjDKEUcdXnqIkolS2mIoxEHIj9M8BOrwwDnxXh7728LkDMMQ81GLDUt93P-NkZuX1H-yh5kV1cpN4W3iAgRz5yi9-hXsz_9ce_89_bgLGCtRt7eXTZBJqqjcFI2dFXcE0bOBssUxz5uTW2P5uaiXaMoTwjBu3kVpFHmsGrv7kNWdhsJf01DxYEuW5Yj4LERIxqUIah9wNuKJSmc1V60DLARRRsb-6afNxJz4ppCOeyMZdkDpsV2L3-QYjPwn4pXaIkj2L9l6gC_xJMKgEC3iVw6bfiDZK1RKFjUvFh17VYbW6jNbJpJxkTyVP2T0MMXmLuXWYy9W3-kovMFl_yhe-f_gKjKC6itPjzskijBLElGYFjDgNGOw_PqklGI6e-930cTmbfxbc_LXavgNiHGbv |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+pathogenesis+of+Parkinson%27s+disease&rft.jtitle=The+Lancet+%28British+edition%29&rft.au=Morris%2C+Huw+R&rft.au=Spillantini%2C+Maria+Grazia&rft.au=Sue%2C+Carolyn+M&rft.au=Williams-Gray%2C+Caroline+H&rft.date=2024-01-20&rft.eissn=1474-547X&rft.volume=403&rft.issue=10423&rft.spage=293&rft_id=info:doi/10.1016%2FS0140-6736%2823%2901478-2&rft_id=info%3Apmid%2F38245249&rft.externalDocID=38245249 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0140-6736&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0140-6736&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0140-6736&client=summon |